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ABSTRACT 
Shewanella are invaluable hosts for the discovery and engineering of pathways important 
for bioremediation of toxic and radioactive metals, to create microbial fuel cells and for 
understanding extracellular electron transfer. However, studies on this species have suffered from 
a lack of effective genetic tools for precise and high throughput genome manipulation. Previously, 
the only reliable method used for introducing DNA into Shewanella spp. at high efficiency was 
bacterial conjugation, enabling transposon mutagenesis and targeted knockouts using suicide 
vectors for gene disruptions.  
In this dissertation, I describe development of simple and efficient genome editing tools 
for precise and site-directed mutagenesis of Shewanella. First, In Chapter I, I review recent 
advances in synthetic biology that accelerate the study and engineering of bacterial phenotypes. In 
chapter II, I show the development of a robust and simple electroporation method in S. oneidensis 
that allows an efficiency of up to ~108 transformants/µg DNA and which is adaptable to other 
strains.  Using this method for DNA transfer, in chapter III, I characterize a new phage recombinase, 
W3 Beta from Shewanella sp. W3-18-1 and show its utility for in vivo genome engineering 
(recombineering) using linear single-stranded DNA oligonucleotides. In my experiments the W3 
Beta recombinase gives an efficiency of ~5% recombinants among total viable cells. In addition, I 
show the functionality of this new system in S. amazonensis, a strain with few genetic studies but 
of interest given its higher temperature range for growth and wide range of carbon sources utilized. 
In chapter IV, I demonstrate use of the CRISPR/Cas9 system as a counter-selection to isolate 
recombinants. When coupled to recombineering, this counter-selection results in an extremely high 
efficiency of >90% among total surviving cells, regardless of the gene or strain modified. This 
efficiency allows isolation of several different types of mutations made with recombineering, and 
even allows identification of rare recombinants that form independently of W3 Beta expression. 
This is the first effective and simple strategy for recombination with markerless mutations in 
Shewanella.	With synthesized single-stranded DNA as substrates for homologous recombination 
and CRISPR/Cas9 as a counter-selection, this new system provides a rapid, scalable, versatile and 
scarless tool that will accelerate progress in Shewanella genomic engineering. Finally, I conclude 
in Chapter V with an overview of the challenges and future directions of the technologies 
demonstrated here, discussing possible advancements that could further enhance the study of 
Shewanella. 
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CHAPTER I: 
INTRODUCTION 
 
1.1. The respiratory versatility of Shewanella 
 
Members of the genus Shewanella form a group of facultative anaerobic gram negative 
bacteria widely distributed in marine and freshwater environments (Venkateswaran et al. 1999; 
Hau & Gralnick 2007). The hallmark of many Shewanella is the ability to utilize a remarkably 
diverse array of final electron acceptors in the absence of oxygen, which allows them to survive in 
extreme and varied environments. As a genus, these organisms have the most diverse respiratory 
abilities described to date (Hau & Gralnick 2007; Venkateswaran et al. 1999). The approximately 
20 organic and inorganic compounds that can be respired by Shewanella include a number of toxic 
elements and insoluble metals (Satomi 2014; Fredrickson et al. 2008). As a result, they show great 
potential for remediation of various environmental pollutants (Tiedje 2002) and in microbial fuel 
cells, where their metabolism is harnessed to make electricity from waste water treatment (Rabaey 
& Verstraete 2005; Lovley 2012). 
S. oneidensis MR-1, formerly Shewanella putrefaciens MR-1, is the best characterized 
strain of Shewanella (Heidelberg et al. 2002). This bacterium was isolated in 1987 from sediment 
from Oneida Lake (Myers & Nealson 1988), New York, and it is found in numerous sedimentary 
environments. As in other species, S. oneidensis uses oxygen as the terminal electron acceptor 
during aerobic respiration; however, under anaerobic conditions, it undertakes respiration by 
reducing alternative terminal electron acceptors. A partial list includes oxidized metals (including 
Mn(III) and (IV), Fe(III), Cr(VI), U(VI)), fumarate, nitrate, trimethylamine N-oxide, dimethyl 
sulfoxide, sulfite, thiosulfate, elemental sulfur and more. A complete list can be found elsewhere 
(Beblawy et al. 2018). Such plasticity in alternative electron acceptors for anaerobic respiration has 
not been observed in any other organism so far.  
The anaerobic respiratory versatility of S. oneidensis is a consequence of its 
multicomponent branched electron transport system (Breuer et al. 2015).  Of particular interest is 
the metal respiratory (Mtr) pathway, which consists of at least five multiheme c-type cytochromes 
(CymA, FccA, STC, MtrA and MtrC) and a porin-like outer membrane protein MtrB (Figure 1.1). 
Cytochrome CymA oxidizes quinol in the cytoplasmic membrane and transfers electrons to 
periplasmic cytochromes FccA and STC, which distribute the electrons to MtrA (Brutinel & 
Gralnick 2012b). A trans-outer membrane protein complex formed by MtrA, MtrB and MtrC 
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transfers the electrons from the periplasm to the extracellular space, where MtrC functions as a 
terminal reductase that interacts with the metal substrates (Beblawy et al. 2018). Unlike other 
pathways, the Mtr pathway is known to be promiscuous; it can reduce 9,10-anthraquinone-2,6-
disulfonic acid (AQDS) and carbon electrodes, as well as soluble substrates that form solids upon 
reduction, such as chelated cobalt, vanadium(V), uranium(VI), technetium(VII) (Beblawy et al. 
2018; Shi et al. 2012; Shi et al. 2016). Development of efficient genome-editing tools allowing site-
directed mutagenesis could help clarify the molecular mechanisms involved in the Mtr pathway 
and promote a better understanding of this promiscuity. Some engineering approaches have been 
applied for large-scale manipulation of Shewanella, although these were based on random 
mutagenesis (Yang et al. 2014; Qiu et al. 2004; Jones et al. 2010), which is useful for gene 
disruption but does not allow the manipulation of essential genes. To better understand the current 
extracellular electron transfer model and to fully exploit the metabolic potential of this family, easy 
and efficient methods for rational genome engineering are needed.  
 
 
Figure 1. 1.  Outline of the Mtr pathway in S. oneidensis MR-1.  
Multiheme c-type cytochromes CymA, FccA/STC, MtrA, MtrC and the porin-like outer membrane 
protein MtrB form an electron conduit to transfer the electrons from carbon source oxidation to the 
outside of the cell. MtrC can reduce insoluble metal substrates in the extracellular space. 
 
1.2. CRISPR-based editing technologies in bacteria 
 
Recently, the CRISPR (clustered regularly interspaced short palindromic repeats)- Cas 
(CRISPR associated) systems have revolutionized  genome engineering in a broad range of 
organisms, from bacteria (Wendt et al. 2016; Wolf et al. 2016; Huang et al. 2015; Tong et al. 2015; 
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Altenbuchner 2016; Cobb et al. 2014; Mougiakos et al. 2017), yeast (Weninger et al. 2016; Ng & 
Dean 2017) to mammalian cells (Richardson et al. 2016; Chu et al. 2015) and plants (Liang et al. 
2016; Kuei & Puchta 2019).  Because of its inherent simplicity, the most exploited CRISPR/Cas 
system is the Class 2 type IIa CRISPR/Cas from S. pyogenes, SpCas9, (Hsu et al. 2015) as further 
explained in chapter IV. The utilization of CRISPR/Cas9 for genome engineering purposes requires 
two components; the nuclease Cas9 and a targeting guide RNA, gRNA (Selle & Barrangou 2015). 
Targeting any site requires only the insertion of a short sequence (20bp) upstream of the gRNA 
scaffold, which matches the target gene sequence, denoted as protospacer, that one desires to 
modify. When co-expressed, the Cas9/gRNA complex can target any DNA sequence, given that a 
short (3nt) motif, the protospacer adjacent motif (PAM) is present downstream of the protospacer 
sequence. The PAM for SpCas9 is 5’-NGG-3’ (Shah et al. 2013). Annealing of the gRNA spacer 
to the target site in the genome leads to a double stranded break (DSB) produced by the Cas9 
nuclease (Selle & Barrangou 2015). 
In eukaryotic cells, the DSB introduced by Cas9 can be repaired by the nonhomologous 
DNA end joining (NHEJ) recombination system, resulting in a mutation at the target site (Komor 
et al. 2017). However, NHEJ either does not work efficiently or is not present in most bacteria 
(Selle & Barrangou 2015). This may be seen as a disadvantage to using CRISPR-Cas9 technology 
for the inactivation of genes by small deletions or insertions (indels). On the other hand, for precise 
gene editing, DSBs may be repaired by homologous recombination using an engineered 
homologous template, a process that is more efficient in prokaryotes than in eukaryotes. Linear 
templates or plasmid-borne templates can be used for homologous recombination (HR) (Selle & 
Barrangou 2015). 
In prokaryotes, an attractive application has been the combination of in vivo recombination-
mediated genome engineering (recombineering) with the use of CRISPR/Cas9 as a counter-
selection tool (Figure 1.2), which has been shown to result in highly efficient genome engineering 
(Yan et al. 2017; Jiang et al. 2013; Ronda et al. 2016; Paix et al. 2016). Recombineering harnesses 
phage recombination proteins for HR of linear DNA donor templates with the bacterial 
chromosome (Sharan et al. 2009). Two recombineering systems have been well characterized for 
genome engineering in E. coli; the λ-Red from phage λ and the RacET from the E. coli Rac 
prophage, each which contain an exonuclease associated with a recombinase (Pines et al. 2015; 
Boyle et al. 2013) that promote HR with the chromosome. Unlike other homologous recombination 
techniques, recombineering allows to efficiently recombine DNA with homologous regions as short 
as 30-50bp, and many mutations can be created, including insertions, deletions or substitutions. 
Linear donor templates in the form of single-stranded DNA (ssDNA) oligonucleotides (oligos) or 
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double-stranded DNA (dsDNA) PCR products can be used (Ellis et al. 2001; Yu et al. 2000). When 
dsDNA is introduced, both the exonuclease (λ-Exo or RecE from the Rac prophage) and its 
associated recombinase (λ-Beta or RecT) are required (Datta et al. 2008), but if ssDNA oligos are 
used, only the recombinase is needed (Ellis et al. 2001). Coupling recombineering to CRISPR/Cas9 
in bacteria results in a powerful hybrid technology as CRISPR/Cas9 here acts as a negative 
selection; no selectable markers are necessary because non-edited cells will die after the DSB 
(Mougiakos et al. 2016). 
 
 
Figure 1. 2. Recombineering coupled to CRISPR/Cas9 counter-selection. 
The exonuclease λ-Exo first processes the dsDNA donor template leaving ssDNA, which λ-Beta 
recombinase anneals and recombines at the target gene (Sharan et al. 2009). CRISPR/Cas9 is then 
induced to eliminate the remaining unmodified cells by creating a DSB in the chromosome, which 
host nucleases further degrade, leading to destruction of unmodified parental chromosomes. A 
silent mutation is usually introduced in the PAM site, in addition to the desired mutations, to 
abrogate Cas9 cleavage of the mutated cells and thus conferring CRISPR immunity (Garst et al. 
2016). 
 
1.3. Genome Editing Technologies for Shewanella 
 
Previous genome editing tools for Shewanella include random chemical (Saffarini et al. 
1994), UV (Qiu et al. 2004) or transposon mutagenesis (Deutschbauer et al. 2011; Brutinel & 
Gralnick 2012a) and targeted deletions (Beliaev & Saffarini 1998) using the traditional suicide-
plasmid technique (Figure 1.3). Although these tools have been useful for elucidation of important 
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genotypic traits of this bacterium, for genome-scale engineering these are neither sufficient nor 
efficient, as these techniques are usually applied to create knock-out mutants.  
In this dissertation, I describe characterization of a new bacteriophage recombinase protein, 
W3 Beta from Shewanella sp. W3-18-1 (NCBI accession WP_011788511, locus sputw3181_1153, 
annotated herein as sw_1153) and demonstration of its utility for in vivo genome engineering 
(recombineering) in S. oneidensis and S. amazonensis, using single stranded DNA (ssDNA) oligos 
as donor templates for HR. Similar to λ-Beta and RecT, W3 Beta allows for the introduction of 
nearly any desired mutation, and requires only 40 nucleotides (nt) of flanking homology to the 
target gene (Corts et al. 2019), as opposed to traditional RecA-mediated double-crossover 
recombination with non-replicative plasmids, which requires long homology regions of ~1kb 
(Coursolle & Gralnick 2010).  
In contrast to random mutagenesis, recombineering allows modification of the genome in 
a precise and targeted way and, as I show in chapter III, an efficiency up to ~5% recombinants 
among total viable cells can be obtained in S. oneidensis. The establishment of ssDNA 
recombineering has been a major advance for Shewanella genome-engineering. However, when 
the introduced mutation(s) do not result in a clear phenotypic change, a PCR-based screen is used 
to identify the recombinants, which can be cumbersome. Thus, in chapter IV, I develop a system 
that couples recombineering to the CRISPR/Cas9-mediated counter-selection. The addition of 
CRISPR/Cas9 in the system now allows to efficiently isolate the recombinant cells up to >90% 
among total cells. 
 
 
Figure 1. 3. Timeline of advances contributing to genome-engineering technologies in 
Shewanella.Refer to the text for details and references.  
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1.4. CRISPR EnAbled Trackable genome Engineering (CREATE) 
 
CREATE is a recently developed high-throughput strategy for generating thousands of 
precise mutant variants in E. coli (Figure 1.5) (Garst et al. 2016; Liang et al. 2017; Liu et al. 2018). 
This technology couples recombineering by the λ Red system with CRISPR/Cas9 as a counter-
selection. A unique characteristic of CREATE is the use of a plasmid-born short donor template 
for homologous recombination using λ-Red. This template is located upstream of the sgRNA 
sequence in the sgRNA expressing plasmid, as shown in Fig. 1.4, which together with the sgRNA 
is called the CREATE cassette. This cassette is then used for mapping and tracking the mutations 
generated into the chromosome (Figure 1.5), as the plasmid carrying the CREATE cassette stays 
in the cell and, thus, it serves as a transacting barcode for the genomic edit, allowing parallel 
genotype-phenotype assessment of designs that are enriched in the population.  
 
 
Figure 1. 4. CREATE cassette for protein engineering. 
A short donor template with flanking homology arms to the targeting gene is synthesized de novo 
together with promoter expressing the gRNA and the gRNA complete sequence. 
 
The CREATE strategy is convenient as thousands of CREATE cassettes can be designed 
in parallel by using a custom CREATE software and synthesized on a microarray platform as large 
pools (104-106 library members) at a cost of	approximately <$0.001/bp. From the microarray, the 
library of cassettes is amplified and cloned into a plasmid in multiplex. After introduction of the 
plasmid library into cells harboring Cas9 and λ-Red, the mutations are transferred to the desired 
target in the genome in just a single step (Fig. 1.5). The great advantage of using this CREATE 
plasmid design is that it ensures that the sequences required to guide cleavage and homologous 
recombination are covalently coupled during the synthesis and cloning, and thus delivered 
simultaneously to the same cell for genome editing. 
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Figure 1. 5. Overview of the CREATE workflow.  
Library design is automated in a software package (http://www.thebioverse.org) and synthesized 
in parallel using microarray-based oligo technologies. The pool of DNA can be cloned in multiplex 
and transformed in cells harboring Cas9 and the λ-Red machinery. High-throughput sequencing of 
plasmid cassettes in the library before and after selective pressure can be leveraged to calculate 
plasmid enrichment and infer the enrichment of the corresponding genomic edit, allowing parallel 
genotype-phenotype mapping of edits that confer an advantage under selective pressure. 
 
CREATE enabled the concurrent evaluation of  >50,000 genome-wide mutations with 
parallel mapping in a single experiment and led to the identification of previously unreported 
mutations that are rarely found by adaptive laboratory evolution (ALE) or error-prone approaches 
(Garst et al. 2016). Additionally, the CREATE tool was employed to introduce multiple RBS 
variations for each of the genes in a chromosomal integrated isopropanol production pathway in E 
.coli, leading to the time-efficient construction and testing of ~1,000 strains (Liang et al. 2017). 
 
1.5. Summary and Objectives 
 
In summary, the work described in this dissertation was designed to address the above-
mentioned limitations on our ability to precisely manipulate Shewanella, by developing and 
demonstrating technologies that facilitate genetic engineering of this organism. In order to achieve 
this goal, I leveraged recent advances in synthetic biology to develop novel technologies that 
improve (1) the ability to accurately perturb the chromosomal DNA and (2) the means to rapidly 
construct and isolate mutants in Shewanella.  
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In Chapter II, I first describe development of a method for electro-transformation of in 
Shewanella spp. Until recently, the only means to transfer DNA in this bacterium was conjugation. 
However, here I show that electroporation is also possible in Shewanella and at very high 
efficiency. Several parameters were tested in order to optimize the efficiency of transformation: 
temperature, optical density and cell growth, amount of DNA and cells, wash buffer, and others. 
The advantage of electro-transformation is that not only circular DNA can be transferred, but also 
linear DNA in the form of dsDNA or ssDNA for genome engineering, which allows integration of 
exogenous DNA by recombineering.  
In Chapter III, I describe discovery of a new phage protein, W3 Beta, and demonstrate its 
utility for high efficiency of recombineering in S. oneidensis. I provide examples for precise editing 
of chromosomal lacZ and rpsL and provide evidence that W3 Beta may be broader host than λ-Red 
Beta and RecT. Next, I demonstrate the application of recombineering in S. amazonensis. The 
results described in Chapters II and III were published as “A new recombineering system for precise 
genome-editing in Shewanella oneidensis strain MR-1 using single-stranded oligonucleotides” 
(Anna D. Corts et al. Nature Scientific Reports. 2019).  
In Chapter IV, I show that the CRISPR/Cas9 technology is functional in different 
Shewanella strains and describe development of a system that couples both recombineering with 
CRISPR/Cas9. I then demonstrate the extremely high efficiency of this new system for making 
different DNA changes; small insertions, point mutations and deletions, regardless of the gene or 
strain to be modified. 
Finally, I conclude in Chapter V with a discussion on limitations that should be addressed 
in order to unlock the full potential of genome engineering in Shewanella, as well as future 
directions for the technologies described in this dissertation.  
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CHAPTER II: 
DEVELOPMENT AND OPTIMIZATION OF AN 
EFFICIENT ELECTROTRANSFORMATION METHOD IN 
SHEWANELLA 
 
This chapter was adapted from “A new recombineering system for precise genome-editing 
in Shewanella oneidensis strain MR-1 using single-stranded oligonucleotides”, published in Nature 
Scientific Reports, in 2019 (Anna D. Corts, et al. 2019), and from “Efficient and Precise Genome 
Editing in Shewanella with Recombineering and CRISPR/Cas9-mediated Counter-selection”, 
submitted in ACS Synthetic Biology, in 2019.	
 
2.1. Introduction 
 
To date, the most reliable method used for introducing DNA into Shewanella spp. has been 
bacterial conjugation, a somewhat tedious and time-consuming technique when compared to 
electroporation-based methodologies.  Shewanella oneidensis strain MR-1 is a widely used 
Shewanella strain but displays a low efficiency of electrotransformation for heterologous plasmids 
derived from different bacterial species, due to its restriction-modification native system 
(Rachkevych et al. 2014). Since the first attempt of electrotransformation in S. oneidensis in 1994 
(Saffarini et al. 1994), only a few studies have used electroporation as a method to transfer DNA 
in Shewanella (Rachkevych et al. 2014; Myers & Myers 1997; Zhou & Ng 2016; Bendall et al. 
2013; Shi et al. 2005), and no robust transformation protocol has been established to date.  
A recent study in the model organism E. coli showed that making electrocompetent cells 
and performing electroporation at room temperature (Tu et al. 2016) improves DNA transformation 
up to 10-fold. Although standard procedure is to keep cells on ice when making electrocompetent 
cells and during electroporation (Wu et al. 2010), we found that preparation of electrocompetent 
cells at room temperature also increases transformation efficiency in S. oneidensis. Additionally, 
we optimized a number of other transformation parameters including DNA concentration, cell 
quantity, growth phase, electroporation conditions and cell competence after freezing at -80 °C. 
We found that when using 10% glycerol as wash buffer, cells grown to stationary phase increases 
electroporation efficiency by nearly 400-fold compared to those from early exponential phase, as 
conventional methods describe. This surprising finding allowed us to make electrocompetent cells 
10 
 
by simply using overnight cultures which, when frozen at -80 °C, still maintain the same high 
transformation efficiency.  
We further improved the efficiency to a maximum of ~108 transformants/ µg DNA by using 
1 M sorbitol as wash buffer and late exponential phase cells and were able to apply this protocol to 
other Shewanella strains as well. 
 
2.2. Results  
 
2.2.1. Room temperature enhances electrotransformation efficiency in S. oneidensis 
 
We tested transformation of plasmids pACYC' (a modified version of pACYC184 (Myers 
& Myers 1997), 2,703bp) with chloramphenicol (Cm) resistance and pBTBX2 (Prior et al. 2010) 
(3,831bp) with kanamycin (Km) resistance, by making electrocompetent cells at room temperature 
(RT). Each plasmid was purified from the methylation-proficient E. coli UQ950 and from a 
methylation-minus E. coli (GM1674 or GM2163). The latter contain a mutation in the DNA-
cytosine methyltransferase (dcm--6) that prevents methylation of cytosine residues, which is useful 
for plasmid purification and transformation into other bacteria because of host modification-
dependent restriction systems (Macaluso & Mettus 1991). 
No matter the plasmid type or source, the electroporation efficiency was consistently higher 
for electrocompetent cells prepared at room temperature (Fig. 2.1a and Fig. 2.2a). In addition, 
transformation efficiencies were higher when plasmids were purified from the methylation-minus 
E. coli, as expected.  
We observed that cell viability decreased between 4- to 10-fold when making 
electrocompetent cells on ice (Fig. 2.1b), suggesting cell lysis, as was observed for E. coli (Tu et 
al. 2016). 
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Figure 2. 1. Electrotransformation efficiency and cell viability at room temperature (RT) and 
ice temperature (IT).  
(a) Transformation efficiency. (b) Cell viability. The error bars represent standard error from three 
independent experiments. Cells were transformed with 250 ng of plasmid pACYC' or pBTBX2 
purified from a methylation-minus (GM) or -proficient (UQ) E. coli. 
 
Further analysis by colony PCR and agarose gel electrophoresis of transformants obtained 
at room temperature indicated successful transformation (Fig. 2.2b). In parallel experiments, mock 
transformations without plasmid produced no colonies on selective agar plates.  
 
 
Figure 2. 2. Comparison of electrotransformation at room temperature (RT) and ice 
temperature (IT).  
(a) Cell plates from transformation at RT and IT with each plasmid, pACYC’ or pBTBX2, purified 
from methylation-minus E. coli GM1674 or GM2163 (GM), respectively. One mL of LB medium 
was added to the samples and the cell suspensions were recovered at 30 °C for 2 h. After the 
recovery step, aliquots of cells were not diluted but 900 µL of cells (pelleted and suspended in 
remaining 100 µL LB) were plated on selective agar plates. (b) Seven transformants from (a) at RT 
transformation with each plasmid were analyzed by colony PCR, which revealed the presence of 
the plasmid as expected. ⊕ indicates a positive plasmid control, ⊘ indicates a negative control S. 
oneidensis with no plasmid. The gel was cropped to show the relevant information and no high-
contrast of the image was used.  
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2.2.2. Development of an efficient electroporation method in S. oneidensis 
 
At room temperature the absolute number of transformants increased, but the efficiency 
was still low. Thus, it was necessary to evaluate other electroporation factors to achieve higher 
efficiency. We optimized these parameters using the larger plasmid pBTBX2 purified from 
methylation-minus E. coli and further verified our observations using pBTBX2 purified from E. 
coli UQ950 and wild-type S. oneidensis.  
Cell density and growth phase are essential parameters that can be manipulated to enhance 
cell transformation efficiency. We investigated the impact of a range of cell densities from early 
exponential phase to late exponential phase. Notably, higher density resulted in a significant 
increase in transformation efficiency, up to ~4x106 transformants/µg DNA using overnight cultures 
at late exponential phase, nearly 400-fold more transformants than at early exponential phase (Fig. 
2.3a). These results are in contrast to E. coli electrotransformation (Wu et al. 2010; Tu et al. 2016; 
Tu 2005), although in agreement with transformation studies in P. aeruginosa (Choi et al. 2006).  
Various amounts of plasmid DNA (0.01 – 1.5 µg) were used to determine the optimal 
concentration for transformation. As we expected, a linear relationship between plasmid DNA 
quantity and number of transformants was observed. Specifically, 0.1 µg was sufficient for high 
transformation efficiency (Fig. 2.3b), suggesting that saturation may occur beyond this 
concentration. Frequency however, resulted in a slight proportional relationship because of a slight 
decrease in cell viability due to dilution of cells as more DNA is added. Cell number is another 
parameter that can be manipulated to increase transformation efficiency. Usually, large volumes of 
cells are used for E. coli transformation(Wu et al. 2010), thus we investigated the effect of using 
higher quantities of cells by varying the cell volume used per electroporation reaction, from 1 to 9 
mL (Fig. 2.3c). When using one mL cells, the total viable cells surviving electroporation was only 
~1.5 x104 cfu/mL and no transformants were obtained, while in three mL, ~1.6 x107 cfu/mL viable 
cells remained after electroporation resulting in the highest efficiency. Increasing the cell volume 
to 6 and 9 mL, slightly increased the total viable cells but no significant difference in the number 
of transformants was observed. Frequency always remained constant, ~2 x10-4 transformants/ 
viable cell, no matter the number of cells surviving. 
Various electroporation parameters had been used in earlier S. oneidensis transformation 
attempts (Rachkevych et al. 2014; Myers & Myers 1997; Zhou & Ng 2016; Saffarini et al. 1994; 
Bendall et al. 2013). We found that washing the cells with dH2O decreased both the transformation 
efficiency and frequency, ~80- and ~200-fold, respectively, compared to results using 10% 
glycerol. In contrast, 1 M sorbitol and electroporation buffer(Weinstock et al. 2016) significantly 
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increased the number of viable cells surviving electroporation, resulting in ~250- and ~10-fold 
higher efficiency, respectively, than the 10% glycerol wash and a similar frequency (Fig. 2.3d). 
The transformation efficiency increased proportionally to the voltage applied, achieving an 
optimum before decreasing at high voltage. Specifically, 12 kV/cm gave the best results, ~1x104 
transformants/µg DNA (Fig. 2.3e) with a time constant of ~5 ms, which results in a 100- to 3,300-
fold increase compared to the other voltages applied. 
Using the optimized procedure, we examined whether storage at −80 °C of late exponential 
phase electrocompetent cells affected transformation yields. Cells frozen for 30 days maintained as 
high a transformation efficiency as freshly prepared cells without loss of competence when stored 
in 10% glycerol (Fig. 2.3f) or 1 M sorbitol (Fig. 2.4). 
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Figure 2. 3. Effects of various parameters on S. oneidensis transformation. 
(a) Cell density. (b) Plasmid DNA amount. (c) Cell volume. (d) Wash buffer. (e) Voltage. (f) Time 
frozen in 10% glycerol at -80 °C (one mL cells was used). Plasmid pBTBX2 purified from 
methylation-minus E. coli GM2163 was used. The error bars represent standard error from three 
independent experiments. Three mL cells were transformed with 250 ng of plasmid DNA, unless 
otherwise specified.  
a b 
c d 
e f 
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Figure 2. 4. Effect of time frozen in 1 M sorbitol at -80 °C on S. oneidensis 
electrotransformation. 
One mL of overnight culture was washed with 1 M sorbitol as described in the Methods section 
and frozen immediately. At the times specified, cells were tested for electrotransformation with 
250 ng of pBTBX2 plasmid DNA isolated from the methylation-minus E. coli strain GM2163. One 
mL of LB medium was added to the samples and the cell suspensions were recovered at 30 °C for 
2 h. Aliquots were plated on LB + Km plates at dilutions to yield single colonies. Transformants 
were counted after ~36 h incubation at 30 °C. The error bars represent standard error from three 
independent experiments. 
 
2.2.3. Effect of plasmid DNA methylation patterns on electroporation efficiency 
 
Intrigued by the high efficiencies observed at stationary phase, we tested whether inhibition 
of the restriction-modification system from the cell was the reason of higher electrotransformation 
efficiencies at stationary phase cells. For that, we performed electroporation using a plasmid with 
different methylation patterns; E. coli and Shewanella methylated.  
We observed a similar increase in transformants using plasmid purified from E. coli UQ950 
and the methylation-deficient E. coli GM2163, ~400-fold higher efficiency compared to results 
with early exponential phase cells. Unexpectedly, when using plasmid DNA purified from S. 
oneidensis (Fig. 2.5), the efficiency only increased ~40-fold, reaching that of wild-type E. coli 
MG1655 (~1x104 transformants/ µg DNA in our lab, using plasmid pBTBX2 purified from E. coli 
UQ950).  
Surprisingly, higher efficiency of electroporation was obtained with the un-methylated 
plasmid compared to the S. oneidensis methylated plasmid. We think the lower efficiencies 
observed using S. oneidensis purified plasmid may be due to the method for plasmid purification, 
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which was initially developed for E. coli, thus may yield lower plasmid amounts when obtained 
from Shewanella. 
 
 
Figure 2. 5. Effect of plasmid DNA methylation patterns on electroporation efficiency.  
250 ng of pBTBX2 plasmid DNA purified from methylation-proficient E. coli UQ950, 
methylation-minus E. coli GM2163 or S. oneidensis MR-1 was used for electroporation. One mL 
of LB medium was added to the samples and the cell suspensions were recovered at 30 °C for 2 h. 
Aliquots were then plated on LB + Km plates at appropriate dilutions to yield single colonies. 
Transformants were counted after ~36 h incubation at 30 °C. The error bars represent standard error 
from three independent experiments.  
 
From this experiment we cannot conclude whether inhibition or changes of the host 
restriction-methylation system are the logic for the enhanced electroporation efficiency. However, 
the results indicate that another unknown factor plays a role since the efficiency increases even 
when the plasmid is methylated with the same host pattern, S. oneidensis. 
 
2.2.4. Application of electroporation to other Shewanella strains 
 
We then wished to apply the developed protocol to other Shewanella strains. Given that 1 
M sorbitol resulted in higher number of transformants when using early exponential phase cells, 
but 10% glycerol gave a very high efficiency when using stationary phase cells, we first sought to 
more precisely compare both wash buffers. Thus, we performed electroporation by using cells at 
different growth phases and made them competent by washing them with 1 M sorbitol or 10% 
glycerol (Figure 2.6.) 
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Surprisingly, we found that sorbitol gives higher electrotransformation efficiencies up to 
late exponential phase when cells are at an OD600 of ~2, resulting in a maximum efficiency of ~108 
transformants/µg DNA and a frequency of one transformant every ~200 viable cells. This 
efficiency numbers were notable as it results in a 100-fold increase compared to the glycerol 
washed cells and 300-fold higher than the transformants obtained with wild-type E. coli. At 
stationary phase cells, however, the same number of transformants is obtained for both the glycerol 
and sorbitol washes. 
Using the same kanamycin resistant plasmid, pBTBX2, successful electrotransformation 
was obtained when using S. amazonensis SB2B cells washed with sorbitol, obtaining an efficiency 
of ~106 transformants/µg DNA. Interestingly, SB2B cells behaved differently than MR-1 cells, the 
efficiency was maintained the same up to OD600~2, but decreased 100-fold when using stationary 
phase cells (Fig. 2.6). SB2B cells were verified by colony PCR and mock electroporations with no 
plasmid DNA showed kanamycin resistant colonies as expected. 
We were also able to obtain kanamycin resistant Shewanella sp. W3-18-1 cells when 
performing the electroporation method using sorbitol as wash buffer, albeit at much lower 
efficiencies (Fig. 2.6). Curiously, although mock transformations resulted in no transformants on 
kanamycin plates, we were unable to PCR verify all the transformant colonies picked from the 
selection plates. Some colonies resulted in the right PCR product from amplification of a region in 
the plasmid backbone, while others showed no PCR amplification. Repeated attempts by colony 
PCR and PCR from purified plasmid resulted in the same outcome. Further experiments would 
need to be done to solve this ambiguity with this strain. 
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Figure 2. 6. Electroporation efficiencies in different Shewanella strains compared to E. coli.  
250 ng of pBTBX2 purified from E. coli GM2163 was used for electroporation. One mL of LB 
medium was added to the samples and cell suspensions were recovered at 30 °C (Shewanella) or 
37°C (E. coli) for 2 h. Aliquots were plated on Km plates at appropriate dilutions to yield single 
colonies. Transformants were counted after ~36 h (Shewanella) or ~20 h (E. coli) incubation. The 
error bars represent standard error from three independent experiments. 
 
Below we describe in detail all the steps of our electroporation protocol, for obtaining the 
highest transformation efficiency in the model Shewanella strain S. oneidensis MR-1, which is also 
functional in S. amazonensis SB2B. 
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Table 2. 1. Gralnick Lab high efficiency electroporation protocol for plasmid transformation 
in S. oneidensis MR-1.  
STEP DESCRIPTION NOTES 
1. Preliminary 
Steps 
 
a) Culture a colony overnight in ~5mL LB 
liquid medium in a 20mL culture tube and at 
30°C with shaking (~200 rpm) 
b) Make 1 M sorbitol pH 7.6  
c) Obtain purified plasmid DNA (if possible, 
preferably from a methylation-minus E. coli) 
* DNA concentration should be 
~100 ng/µL. Use a Nanodrop if 
available; if 260/230 and 280/260 
ratios are not ~2 and ~1.8, 
respectively, the efficiency may be 
lower 
2. Making 
electrocompetent 
cells at room 
temperature 
 
 
a) Subculture cells to a starting OD600 of 
0.08 
b) Prepare ~100 ng plasmid DNA in a 2 mL 
Eppendorf tube. Perform a control with no 
DNA 
b) Once cells are at OD600 ~2, collect 3 mL, 
1 mL per Eppendorf tube, spin at 7,906 rcf 
for 1 min 
c) Combine the three pellets into one by 
washing with 1 mL 1 M sorbitol, and spin 
again 
d) Wash cells for a total of three times with 
1 M sorbitol and spinning at 7,906 rcf for 1 
min  
e) After the third wash, decant the sorbitol 
and leave ~60-70 µL for suspending the 
cells 
f) Suspend cells gently by shaking the tube 
and pipetting with P100, then mix cells with 
the DNA by swirling around with the tip 
*When suspending cells with 
sorbitol, be gentle pipetting with 
P1000 ~10 times 
* When decanting sorbitol after 
spins, use care to not lose the 
pellet; gently tap the tube 3 times 
*A 0.1 cm cuvette fits ~100 µL 
max. A 0.2 cm cuvette requires 
higher voltages 
* If desired, use 10% glycerol to 
freeze the cells at -80°C, as 
glycerol is a better buffer to 
maintain cells competent(Corts et 
al. 2019)  
3. Performing 
electroporation 
at room 
temperature 
 
 
a) Transfer the mixture immediately into a 
0.1 cm cuvette without making bubbles 
b) Electroporate at 1.2 kV. Time constant 
(tc) should be ~4 
c) Quickly add 1 mL LB into the cuvette and 
mix gently while pipetting up and down 
d) Transfer the cells into the same 2 mL tube 
you had the DNA in 
e) Let the cells recover at 30°C for 2 h with 
shaking ~200 rpm 
* Electroporator settings: 10 µF, 
600 Ω (if different, voltage may 
need to be optimized) 
* If tc is not ~4, efficiency may be 
lower 
4. Plating 
 
 
a) Make 10x serial dilutions in LB 
b) Plate several different dilutions 
c) Incubate plates at 30°C for ~24-36 h until 
colonies appear 
* Depending on the source of the 
DNA, efficiency varies(Corts et al. 
2019). Maximum efficiency 
obtained here is ~108 
transformants/µg DNA, which is 1 
transformant every ~200 viable 
cells (Fig. S1) 
* No colonies should appear on the 
control with no DNA (if the cells 
are not diluted enough, false 
positives can appear on a lawn of 
dead cells, depending on the 
antibiotic used) 
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2.3. Discussion 
 
The ability to transfer exogenous DNA into cells is essential for genetic engineering of 
microorganisms. Although conjugation has been widely used as means to transfer plasmid DNA in 
bacteria, electroporation is more convenient for large-scale studies and allows transfer of both 
circular and linear DNA molecules. 
The simple and highly efficient electrotransformation protocol reported in this study 
provides an opportunity to more easily manipulate S. oneidensis. Key features of this 
electroporation procedure are using small quantities of cells, using cells at late exponential phase, 
washing with 1 M sortbiol and making electrocompetent cells and performing electroporation at 
room temperature to avoid lysis. With these conditions, ~108 transformants/µg DNA were obtained 
using a non-methylated plasmid.   
For a simple plasmid transformation, stationary phase cells from an overnight culture can 
also be used, producing ~106 transformants/µg DNA with either 10% glycerol or 1 M sorbitol, 
which efficiency was maintained when cells were frozen for long term storage at -80 °C (up to a 
month tested). We were surprised by the high efficiency achieved under this condition compared 
to early exponential phase, as this does not replicate across different bacteria (Tu et al. 2016; Wu 
et al. 2010; Tu 2005), although it is in agreement with P. aureginosa procedures (Choi et al. 2006). 
We do not know why this difference in preferred growth phase prior to electroporation. We suspect 
it is not due simply to a higher input of viable cells, but possibly also to a reduced level of host 
nuclease activity in stationary phase and other unknown factors.  
 
2.4. Materials and Methods 
  
2.4.1. Bacterial Strains, plasmids and culture conditions 
 
All strains and plasmids used in this study are listed in Table S1. Shewanella was routinely 
grown in LB liquid medium or on LB agar at 30 °C. When needed, culture media was supplemented 
with chloramphenicol (Cm, 6.5 µg/mL), kanamycin (Km, 50 µg/mL) or spectinomycin (Spect, 50 
µg/mL). Plasmid pACYC' was isolated from E. coli UQ950 and from methylation-minus E. coli 
GM1674, while plasmid pBTBX2 from UQ950 and methylation-minus E. coli GM2163.  
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Table 2. 2. Strains and plasmids used in this work. 
Strain or plasmid Description Reference or source 
Strain   
JG274 S. oneidensis MR-1, wild type Gralnick Lab 
JG239 Shewanella sp. W3-18-1 Gralnick Lab 
JG2150 S. oneidensis MR-1, lacZ Gralnick Lab 
JG98 S. amazonensis SB2B Gralnick Lab 
   
UQ950 E. coli DH5α λ (pir) host for cloning (Saltikov & Newman 2003) 
GM2163 E. coli methylation-minus, CmR CGSC#: 6581 
GM1674 E. coli methylation-minus CGSC#7971 
MG1655 E. coli F- lambda- ilvG- rfb-50 rph-1 Gralnick Lab 
   
Plasmid   
pACYC' Modified pACYC184, p15a ori, CmR (Myers & Myers 1997) 
pBTBX2 pBBR1 ori, KmR, pBAD (Prior et al. 2010) 
	
2.4.2. DNA manipulations 
 
Plasmid DNAs were isolated using Invitrogen Plasmid mini Kit. The pACYC’ plasmid is 
a modified version of pACYC184 (Myers & Myers 1997) harboring the chloramphenicol resistance 
gene (cmR); the tetracycline resistance gene (tetR) was removed by inserting the oriT RP4 in its 
place, since tetR shared 94bp homology to another region in the plasmid backbone, the promoter 
of cmR was replaced by the promoter of tetR and, nucleotides 442-586 were removed due to 145bp 
shared homology to the E. coli MG1655 genome.  
All plasmids listed in Table 2.2 were created using Gibson Assembly Ultra Kit (Synthetic 
Genomics), except for removal of nucleotides 442-586 in pACYC184, which was performed by 
blunt ligation using NEB T4 DNA ligase. Primers listed in Table 2.3 were used to create linear 
dsDNA by PCR amplification in a 50 µL reaction with Q5 polymerase. The linear dsDNA vectors 
were DpnI digested for at least 2 hours and gel-purified. Inserts were amplified in a 50 µL reaction 
with Q5 polymerase and PCR purified. DNA fragments were assembled at a ratio 1/1 following 
supplier instructions and transferred in chemically competent E. coli UQ950. Cells were recovered 
for ~2 h in LB medium, plated on selective agar plates and incubated at 37 °C.  
For colony PCR, a single colony was transferred to 25 µL dH2O, boiled at 95 °C for 5 min 
and frozen at -80 °C for 5 min. The cell debris was removed by centrifugation for 1 min and 2 µL 
of the supernatant were used as a source of template in a 20 µL reaction. GoTaq 2X MM (Promega) 
was used and supplier instructions were followed. After PCR, 10 µL aliquots were analyzed by 
agarose gel electrophoresis. 
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Table 2. 3. Primers used in this study.  
Name Sequence (5’-> 3’)a Description 
Primers for plasmid modification of pACYC184 (Myers & Myers 1997) 
ADC143 TATGGGGCTGACTTCAGGTGC Rev primer to linearize pACYC184 for cloning oriT 
ADC144 TAACGGATTCACCACTCCAAG For primer to linearize pACYC184 for cloning oriT 
ADC145 gcacctgaagtcagccccataTGTAGACTTTCCTTGGTGTATCCAACG 
For primer for cloning oriT RP4 in 
pACYC184 
ADC146 cttggagtggtgaatccgttaGAATAAGGGACAGTGAAGAAGGAACAC 
Rev primer for cloning oriT RP4 in 
pACYC184 
ADC147 GCAGACCAAAACGATCTCAAGAAG 
For primer to sequence verify oriT RP4 
cloning  
ADC158 
caacttttggcgaaaatgagacgtCGATATA
AGTTGTAATTCTCATGTTTGAC
AGCTT 
For primer to amplify the tetR promoter 
ADC159 tggtatatccagtgatttttttctccatACACGGTGCCTGACTGC 
Rev primer to amplify the tetR promoter 
ADC160 ATGGAGAAAAAAATCACTGGATATACCA  
For primer to linearize pACYC184 for 
cloning PtetR 
ADC161 ACGTCTCATTTTCGCCAAAAGTTG 
Rev primer to linearize pACYC184 for 
cloning PtetR 
ADC170 gcgaagtgatcttccgtcacagGGCTTACTATGTTGGCACTGATGAG 
For primer to linearize pACYC184 to 
remove nucleotides 442-586, creating 
pACYC' 
ADC171 ctcatcagtgccaacatagtaagccCTGTGACGGAAGATCACTTCGC 
Rev primer to linearize pACYC184 to 
remove nucleotides 442-586, creating 
pACYC' 
ADC172 GGCTTACTATGTTGGCACTGATGAG 
For primer to blunt ligate pACYC' 
ADC173 CTGTGACGGAAGATCACTTCGC Rev primer to blunt ligate pACYC' 
ADC174 CCCGTTCGTAAGCCATTTCC For primer to sequence verify removal of nucleotides 442-586 
 
Primers for plasmid analysis 
 
ADC44 GTTTCACTTGATGCTCGATGAG For primer to check for the presence of 
plasmid pBTBX2 in the cells 
ADC105 AATCCCTGTGGTCAAGCTCG Rev primer to check for the presence of 
plasmid pBTBX2 in the cells 
ADC10 CAGGCATTTGAGAAGCACACG
G 
For primer to check for the presence of 
plasmid pACYC' in the cells 
ADC9 GCGATGCAGATCCGGAACAT Rev primer to check for the presence of 
plasmid pACYC' in the cells 
a Lower case designates Gibson assembly overhangs. 
 
2.4.3. Preparation of competent cells and electrotransformation 
 
Shewanella cells were made competent by using a microcentrifuge-based procedure similar 
to that of P. aeruginosa (Choi et al. 2006). Overnight cultures were diluted to an OD600 of 0.08 and, 
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once the cells reached an OD600 between 0.4-0.5 (~4x108 CFU/ mL) (unless otherwise specified), 
three mL of cells were used per electroporation reaction. One mL was distributed per eppendorf 
tube and the cells were harvested at room temperature for one min at 7607 rcf. One mL of room 
temperature 10% glycerol or 1 M sorbitol was used to wash and combine three cell pellets into one. 
The cell pellets were washed two more times and suspended in the residual ~50 µL, which resulted 
on average 106-107 viable bacteria after electroporation. When overnight cultures were used, the 
washing steps were performed at 7607 rcf for two min. If competent cells were to be stored, cells 
were immediately frozen on liquid nitrogen and transferred to -80 °C. When using frozen cells for 
electrporation, a 10 min defrost was allowed on ice followed by three min incubation with the 
plasmid DNA at room temperature prior to electroporation. 
 For electroporation, 250 ng of plasmid was mixed with ~50 µL of competent cells and the 
mixture was transferred to a room temperature 0.1 cm cuvette. After applying a pulse (settings: 10 
µF, 600 Ω, 1.2 kV on a Bio Rad MicroPulserTM), one mL of room temperature liquid LB was added 
and transferred into a two mL Eppendorf tube for greater aeration. Cells were recovered at 30°C 
shacking for two hours prior to plating on agar plates with antibiotics. The plates were incubated 
at 30 °C until colonies appeared. To determine number of viable cells, 10 µL of a range of 10-fold 
serial dilutions were spotted onto LB agar. To determine the number of transformants, 100 µL of 
the aliquots were plated on selective plates at appropriate dilutions to yield single colonies. For the 
lower efficiency conditions, the remaining cells (pelleted at 6,010 rcf for three min and suspended 
in remaining 100 µL LB) were also plated. 
For the ice-chilled electrotransformation, competent cells were kept on ice for 15 min and 
then washed with cold 10% glycerol while keeping the tubes on ice. Electroporation was done with 
ice-chilled cuvettes.  
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CHAPTER III: 
A NEW RECOMBINEERING SYSTEM FOR PRECISE 
GENOME-EDITING IN SHEWANELLA USING SINGLE-
STRANDED OLIGONUCLEOTIDES 
 
This chapter was adapted from “A new recombineering system for precise genome-editing 
in Shewanella oneidensis strain MR-1 using single-stranded oligonucleotides”, published in Nature 
Scientific Reports, in 2019 (Anna D. Corts, et al. 2019), and from “Efficient and Precise Genome 
Editing in Shewanella with Recombineering and CRISPR/Cas9-mediated Counter-selection”, 
submitted to ACS Synthetic Biology, on April 2019.	
 
3.1. Introduction 
 
Developing a high efficiency method for DNA uptake in S. oneidensis has enabled us to 
introduce single-stranded DNA oligonucleotides (oligos) to perform in vivo homologous 
recombination–mediated genetic engineering, known as recombineering, a powerful tool for 
precise DNA editing developed in E. coli. Recombineering enables efficient and rapid in vivo 
construction of mutant alleles by taking advantage of homologous recombination mediated by 
expression of bacteriophage proteins, such as the Red system from phage λ and the RecET system 
from the Rac prophage. Linear DNA fragments, either double-stranded DNA (dsDNA) or single-
stranded DNA (ssDNA) can be designed with short homology sequences, as short as 50 base pairs 
(bp), to a genomic target allowing accurate insertion, deletion or alteration of any DNA sequence 
without relying on conveniently located restriction sites (Sharan et al. 2009; Boyle et al. 2013; 
Sawitzke et al. 2011).  
The λ Red system includes three proteins: Exo, Beta, and Gam. Exo is an exonuclease, 
which degrades DNA in the 5’ to 3’ direction creating 3’ ssDNA overhangs; the recombinase Beta 
is a single-strand annealing protein, which binds to these ssDNA overhangs and pairs them with 
complementary ssDNA targets (Murphy 1998). Exo and Beta are functionally equivalent although 
not related at the sequence level to RecE and RecT, respectively. The Gam protein inhibits the 
RecBCD and SbcCD nuclease activities in the host, protecting the exogenous DNA from being 
degraded (Murphy 1991). The Rac prophage does not encode a known analogue of Gam, but a 
study showed it can be combined with RecET (Zhang et al. 1998). Recombineering with dsDNA 
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requires the presence of both exonuclease and recombinase (Datta et al. 2008), but ssDNA 
recombineering only requires the expression of the recombinase (Ellis et al. 2001).  
Adapting recombineering for a new species is challenging; however, because the λ Red 
and RecET systems do not necessarily maintain high efficiency across different bacteria (Huang et 
al. 2017; Hossain et al. 2015; Hu et al. 2014), there may be a dependence on host-specific 
machinery (Datta et al. 2008; Muyrers et al. 2000). Since recombineering was first applied in E. 
coli (Datsenko & Wanner 2000; Baba et al. 2006), a few other phage homologous recombination 
systems have been found to promote recombination in Pseudomonas, Vibrio, Lactobacillus, 
Mycobacteria, Photorhabdus and Staphylococcus (van Kessel & Hatfull 2007; Yin et al. 2015; 
Yang et al. 2015; Swingle, Bao, et al. 2010; Oh & Van Pijkeren 2014; Aparicio et al. 2018; Penewit 
et al. 2018; Lee et al. 2017; Datta et al. 2008), and we have explored whether this technology can 
be established in Shewanella. To maximize the recombination efficiency, we identified λ Red 
recombinase homologs in Shewanella species and have tested a system from Shewanella sp. W3-
18-1 (Yang et al. 2013). Here, we demonstrate the use of Shewanella sp. W3-18-1 recombinase, 
which shares 55% identity to the λ Red Beta recombinase from E. coli phage λ, for targeted 
mutagenesis using ssDNA in S. oneidensis as well as S.amazonensis. This recombinase is also 
active in wild type E. coli MG1655, achieving higher levels of recombination than RecT and 
comparable to λ Red Beta. This recombineering process, outlined in Fig. 3.1, can increase the ease 
with which complex genome engineering efforts are completed in Shewanella. In contrast to other 
mutagenesis methods, this technology allows precise editing at the single nucleotide level in a few 
days. 
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Figure 3. 1. Representation of the stepwise approach used for recombineering in S. oneidensis. 
The system consists of one plasmid, pX2SW3Beta, expressing the recombinase W3 Beta 
(sw_1153) from the inducible arabinose promoter which is regulated by the arabinose repressor 
(araC). The plasmid is introduced into host cells by electrotransformation, followed by plating on 
LB + Km and growth at 30°C. The recombinase resident in the resulting strain is induced with 
arabinose and the cells are made electrocompetent. ssDNA oligos are transferred by electroporation 
to generate targeted mutations. After recovery, the cells are plated on LB + Km and incubated at 
30°C. Mutants are then screened by PCR and the process can be repeated. 
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3.2. Results  
 
3.2.1. W3 Beta from Shewanella sp. W3-18-1 is homologous to λ-Red Beta 
 
First, we tested for any toxicity effect when expressing the recombinases under the 
arabinose (ara) inducible pBAD promoter in the pBTBX2 plasmid. Unexpectedly, λ Red Beta 
caused a significant growth defect when expressed in S. oneidensis at low levels of induction of 1 
mM ara. No change in growth was observed when expressing RecT up to 5 mM ara (Fig. 3.2).  
We also searched for a new recombinase from a native Shewanella phage and identified a 
potential λ Red Beta homolog (Fig. 3.3) in Shewanella sp. W3-18-1, termed W3 Beta (NCBI 
accession WP_011788511, locus Sputw3181_1153, annotated herein as sw_1153), which did not 
adversely affect cell growth when induced (Fig. 3.2) . 
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Figure 3. 2. Effect of recombinase expression on S. oneidensis growth.  
(a) Effect of varying arabinose concentration on viability of wild-type cells (WT), cells carrying 
the empty vector pBTBX2 and cells with the vector expressing the recombinase under pBAD (W3 
Beta, RecT or λ Red Beta). (b) Colony forming units from a range of 10-fold serial dilutions. Cells 
were subcultured to a starting OD600 of 0.08 and grown to an OD600 of ~0.4-0.5 and then, the 
specified arabinose concentration was added. Cells were induced for 3 h and after induction, 
aliquots were spotted onto LB agar (WT cells) or LB + Km (cells with plasmid) at different 
dilutions.  Colonies were counted after ~24 h incubation at 30 °C. The error bars represent standard 
error from three independent experiments. 
 
a	
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Figure 3. 3. Recombinase protein alignments.  
The National Center Biotechnology Institute Blastp tool was used. Yellow highlighting indicates 
exact identity, whereas green indicates similarity. (a) W3 Beta versus λ Red Beta. (b) W3 Beta 
versus RecT.  
 
3.2.2. Recombineering of lacZ in S. oneidensis  
 
We first evaluated oligo recombineering mediated by λ Red Beta and RecT by targeting 
the E. coli lacZ gene integrated in a single copy on the S. oneidensis chromosome. Although in our 
plasmid transformation optimization we obtained higher efficiencies using late exponential phase 
cells, actively replicating chromosomes is fundamental when performing recombineering as these 
recombinases exploit replication forks (Thomason et al. 2016), thus we used cells at early 
exponential phase. Additionally, sorbitol was used as wash buffer since it gave the best results 
when using early exponential phase cells. 
Previous studies in E. coli show that most single base pair mistmatches as well as insertions 
up to three nucleotides are corrected by the methyl-directed mismatch repair (MMR) system present 
in the cell (Modrich 1991; Costantino & Court 2003; Sawitzke et al. 2011). On this basis, we used 
synthetic ssDNA oligos containing a 10 nucleotide (nt) mutation to disrupt lacZ (Fig. 3.4a), which 
evades the MMR and causes a mutant lacZ- phenotype that can be identified by white/blue 
screening(Shuman & Silhavy 2003).  
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Figure 3. 4. Disruption of chromosomal lacZ in S. oneidensis.  
Sequence corresponding to the site of the mutation is shown in bold. A recombinogenic 
oligonucleotide was utilized to introduce ten consecutive base pair changes, which resulted in 10 
bp mutations coupled with a frameshift, shown in red. 
 
Unexpectedly, ~1x104 recombinants in 108 viable cells were obtained without the 
expression of a heterologous recombinase, suggesting that a low level of recombination occurs by 
a recombinase-independent process. However, neither λ Red Beta or RecT were functional, since 
the number of recombinants obtained was marginally above the minus-recombinase control (Fig. 
3.5a). Thus, we then tested the new recombinase W3 Beta, which was highly efficient for oligo 
recombineering (Fig. 3.5a), obtaining ~5x106 recombinants in 108 viable cells. No recombinants 
were observed in control experiments lacking the oligo in the system.  
Tu and colleagues (Tu et al. 2016) found that λ Red recombineering of a plasmid with 
dsDNA in E. coli was improved ~3-fold when the electrocompetent cells were prepared on ice and 
shifted to room temperature for three minutes prior to electroporation. We sought to test 
recombineering with W3 Beta in S. oneidensis by preparing the electrocompetent cells at different 
temperatures. We found that room temperature prepared cells resulted in ~6-fold more 
recombinants when compared to preparing cells on ice, even if we allowed transient swelling of 
the cells for three minutes at room temperature (Fig. 3.5b). As in our plasmid transformations, we 
observed a decrease in cell viability when cells were prepared on ice. Similarly to E. coli (Sawitzke 
et al. 2011; Costantino & Court 2003), most colonies were still lacZ+, sectored blue and white, 
indicating the segregation of recombinant chromosomes in the original recombinant cell. Sectored 
colonies were streaked for isolated lacZ- pure colonies, followed by PCR amplification of lacZ and 
sequencing of 27 colonies from these different temperature tests, which confirmed the mutations 
introduced (Fig. 3.5d).  
It has been shown in E. coli  that 40nt of homology upstream and downstream of the target 
site is sufficient to achieve high efficiency of oligo recombineering (Sawitzke et al. 2011). We 
tested the system using oligos containing different length of homology arms ranging from 40nt to 
80nt to find the minimum optimal length in S. oneidensis. Although 80nt resulted in higher 
efficiency, generating up to ~5% recombinants among treated cells, the difference was marginal, 
as we obtained ~3% recombinants with the shortest 40nt homology length (Fig. 3.5c).  
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A clear bias for oligo annealing to the lagging strand versus the leading strand has been 
demonstrated in E. coli (Datta et al. 2008; Thomason et al. 2016; Ellis et al. 2001; Costantino & 
Court 2003). We sought to evaluate this bias with W3 Beta in S. oneidensis. All the oligos tested 
corresponding in sequence to the leading strand and thus complement to the lagging strand (lag-
strand oligo) generated higher numbers of recombinants than the oligos complementing the leading 
strand (lead-strand oligo) (Fig. 3.5c). 
 
 
Figure 3. 5. Recombineering of lacZ in S. oneidensis using W3 Beta recombinase.  
(a) Activity of different recombinases when expressed exogenously in S. oneidensis compared to 
recombinase-independent (pBTBX2 empty plasmid) recombination and a mock transformation 
control lacking mutagenic oligonucleotide (80nt homology arms, lag-strand oligo). (b) Effect of 
temperature when making electrocompetent cells on recombineering. Cells were prepared at room 
temperature or kept on ice (15 or 60 min before washing) followed by the conventional preparation 
on ice prior to electroporation (80nt homology arms, lag-strand oligo). (c) Homology arm length 
of the oligo and targeting strand effect on recombineering. The number of recombinants was 
calculated based on the lacZ- colonies on the X-gal plate. The error bars represent standard error 
from three independent experiments. (d) Sequence confirmation of recombinants identified by 
white/blue screening, which revealed the mutation of the DNA sequence ACGGG to 
TAATAAGTAA for all samples, as expected (10 mutants are shown here). 
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3.2.3. Recombineering of rpsL in S. oneidensis  
 
We further demonstrate oligo recombineering targeting a native gene in the chromosome 
of S. oneidensis, the rpsL gene. A recombinogenic oligo targeting the lagging strand (Fig 3.6a) with 
short homology arms of 40 nt was used (Fig. 3.6b). Similar to Swingle and colleagues (Swingle, 
Bao, et al. 2010; Swingle, Markel, et al. 2010), the oligos were designed to introduce 4 bp changes 
containing the K43R (AAA->CGG) mutation, which confers streptomycin resistance (StrepR), and 
a synonymous mutation in P42 (CCT->CCA) to evade MMR (Fig. 3.6b).  
 
 
Figure 3. 6. Mutagenesis of chromosomal rpsL in S. oneidensis.  
(a) Organization of the S. oneidensis MR-1 chromosome showing the location of rpsL respective 
to the origin of replication (oriC). The relative position of oriC (determined using DoriC database) 
and terminus (estimated as the location of the origin plus half of the chromosome length) define 
two replichores through which DNA synthesis proceeds. As the oligos mimic Okazaki fragments 
at the replication fork, the orientation of the target gene in respect to the oriC needs to be known 
beforehand for an optimal recombineering efficiency. Shown in red is the 5’→ 3’ alignment of the 
recombinogenic oligo, complement to the lagging strand template, to target rpsL. (b) Sequence 
corresponding to the site of the mutation is shown in bold. A recombinogenic ooligo targeting the 
lagging strand was utilized to introduce four consecutive base pair changes, which resulted in the 
K43R mutation and a synonymous mutation in P42, shown in red. 
 
Because the frequency of recombination was determined by the number of colonies that 
grew on streptomycin-containing LB agar, a longer outgrowth was necessary to allow segregation 
of the recombinant allele before selection (Fig. 3.7a). Again, a difference in efficiency was 
observed based on the target strandedness, specifically ~3x106 and ~3x104 recombinants were 
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obtained when targeting the lagging and leading strand, respectively (Fig. 3.7b). The percentage of 
recombinants among viable cells was lower than when editing lacZ, ~1% targeting the lagging 
strand, due to the increased recovery step to obtain pure rpsLK43R genotypes (Pines et al. 2015). 
Without the addition of the recombinase in the cells, ~3x104 recombinants were obtained by 
targeting the lagging strand, in agreement with our lacZ editing experiments. Ten mutants each 
from the + and – recombinase experiments were screened by colony PCR with a reverse primer 
specific to the mutation introduced, which revealed that all recombinants contained the correct 4 
bp change (Fig. 3.8a). Sequencing further confirmed the success of the experiment (Fig. 3.8b). 
 
 
Figure 3. 7. Recombineering of rpsL in S. oneidensis using W3 Beta recombinase.  
(a) Effect of recovery time on recombineering of the rpsLK43R oligo (40nt homology arms, lag-
strand oligo). (b) Targeting strand effect on recombineering compared to recombinase-independent 
and mock transformation lacking mutagenic oligonucleotide controls (40nt homology arms oligo, 
2 h recovery).  The number of recombinants was calculated based on the SpectR colonies. The error 
bars represent standard error from three independent experiments.  
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Figure 3. 8. S. oneidensis rpsLK43R recombinants verification.  
Mutants were identified as streptomycin resistant (StepR) colonies. (a) Ten mutants from each 
experiment, the + W3 Beta and  – W3 Beta (pBTBX2 empty plasmid control), were screened by 
colony PCR with a reverse primer specific to the DNA change introduced, validating the correct 
mutation in all colonies. ⊘ indicates a PCR negative control of wild-type rpsL. The gel was 
cropped to show the relevant information and no high-contrast of the image was used. (b) Sequence 
confirmation of 6 recombinants identified by StrepR from each experiment, which further revealed 
the mutation of the DNA sequence TAAA to ACGG for all samples, as expected. 
 
3.2.4. Recombineering of rpsL in S. amazonensis 
 
In order to asses our system in S. amazonensis, we employed the same methodology and 
targeted the lagging strand of the rpsL (Figure 3.9). Using an oligo with 40 nt homology arms 
(Table 3.3), we obtained ~105 spectinomycin resistant (SpectR) CFUs among total viable cells 
(Figure 3.10a), a ~100-fold lower frequency compared to MR-1 (Corts et al. 2019). However, 
colony PCR and sequencing confirmed the engineered mutation TAAG-> ACGG (Figure 3.10b, 
c). 
We observed that S. amazonensis is slightly resistant to 100 µg/ ml spectinomycin; about 
103 cfu/mL were obtained in the controls with either no oligo or no recombinase present (Figure 
3.10a). Increasing the concentration of spectinomycin did not eliminate this background. 
Although, ssDNA recombineering may require some optimization in S. amazonensis, this 
efficiency is adequate to allow construction of single mutants and shows promise for the application 
in other Shewanella strains when electroporation is possible 
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Figure 3. 9. Mutagenesis of chromosomal rpsL in S. amazonensis.  
(a) Organization of the S. amazonensis SB2B chromosome showing the location of rpsL respective 
to the origin of replication (oriC). The relative position of oriC and terminus (estimated as the 
location of the origin plus half of the chromosome length) define two replichores through which 
DNA synthesis proceeds. As the oligos mimic Okazaki fragments at the replication fork, the 
orientation of the target gene in respect to the oriC needs to be known beforehand for an optimal 
recombineering efficiency. Shown in red is the 5’→ 3’ alignment of the recombinogenic oligo, 
complement to the lagging strand template, to target rpsL. (b) Sequence corresponding to the site 
of the mutation is shown in bold. A recombinogenic oligo targeting the lagging strand was utilized 
to introduce four consecutive base pair changes, which resulted in the K43R mutation and a 
synonymous mutation in P42, shown in red. 
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Figure 3. 10. Recombineering in S. amazonensis SB2B.  
(a) Total SpectR colonies from recombineering with W3 Beta and SAMArpsLK43R ssDNA oligo 
(40nt homology arms, lag-strand oligo). A minus-recombinase and a minus-oligo control are 
included. Cells were grown to early-exponential phase with arabinose to induce W3 Beta, then cells 
were made electrocompetent and ssDNA oligo was transformed. Cells were recovered for 2 hours 
prior to plating on LB + km + Spect. The error bars represent standard error from three independent 
experiments. (b) 10 mutants were screened by colony PCR with a reverse primer specific to the 
DNA change introduced, validating the correct mutation in all colonies. ⊘ indicates a PCR 
negative control of wild-type rpsL. The gel was cropped to show the relevant information and no 
high-contrast of the image was used. (c) Sequence confirmation of recombinants identified as 
SpectR, which revealed the mutation of the DNA sequence TAAG to ACGG for all samples, as 
expected (6 mutants are shown here). 
	
3.2.5. W3 Beta is a broad host recombinase 
 
Surprisingly, W3 Beta was also functional in E. coli at an efficiency comparable to λ Red 
Beta. In fact, we observed that preparing electrocompetent cells and performing electroporation at 
room temperature also increased the number of recombinants ~5-fold when using λ Red Beta and 
W3 Beta in E. coli (Figure 3.11a), in contrast to the dsDNA plasmid recombineering previous 
findings (Tu et al. 2016).  Accomplishment of the DNA change introduced by W3 Beta was 
confirmed by colony PCR of 14 mutants with a reverse primer specific to the mutation and 
sequencing of 10 colonies (Figure 3.11b,c).	  
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Figure 3. 11. ssDNA recombineering in E. coli MG1655 by preparing electrocompetent cells 
at different temperatures.  
(a) Comparison of λ Red Beta and W3 Beta activity in ssDNA recombineering using a lag-strand 
targeting oligo with 80nt homology arms to disrupt lacZ, as shown in Fig. 3.4. The number of 
recombinants was calculated by scoring blue colonies containing white sectors on the LB + Km + 
X-gal agar plates. The error bars represent standard error from three independent experiments. (b) 
Sectored colonies were streaked for isolated lacZ- pure colonies and screened by colony PCR with 
a reverse primer specific to the DNA change introduced, validating the correct mutation in all 
colonies. ⊘ indicates a PCR negative control of wild-type lacZ. The gel was cropped to show the 
relevant information and no high-contrast of the image was used. The molecular size marker was 
run on the same gel as the samples shown. The white line indicates the gel contained other samples 
not relevant. (c) Sequence confirmation of 10 recombinants identified by white/blue screening, 
which revealed the mutation of the DNA sequence ACGGG to TAATAAGTAA for all samples, 
as expected. 
 
3.3. Discussion 
 
Homologous recombination using phage functions, known as recombineering, which has 
been coupled with electrotransformation in E. coli (Sharan et al. 2009) and a few other bacteria 
(van Kessel & Hatfull 2007; Yin et al. 2015; Yang et al. 2015; Swingle, Bao, et al. 2010; Oh & 
Van Pijkeren 2014; Aparicio et al. 2018; Penewit et al. 2018; Lee et al. 2017), is a powerful tool 
for in vivo genome editing. In E. coli, recombineering has enabled targeted multiplexed editing 
strategies such as MAGE (Multiplex Automated Genome Engineering) (Wang et al. 2009), TRMR 
(Trackable Multiplex Recombineering) (Warner et al. 2010) and CREATE (CRISPR EnAbled 
Trackable genome Engineering) (Garst et al. 2016), all which take advantage of massive DNA 
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delivery by electroporation, highlighting the importance of this transformation method when 
performing recombineering experiments.  
In contrast to traditional genetic engineering strategies, recombineering allows researchers 
to rapidly and precisely introduce a variety of changes using linear DNA fragments. The use of 
ssDNA for recombineering, which was first described in E. coli over ten years ago (Ellis et al. 
2001), is independent of a selective marker, does not leave any extraneous genetic scars and is 
mechanistically simpler than using dsDNA, requiring only the expression of the recombinase alone. 
However, the well-studied λ Red Beta and RecT recombinases were not functional in S. oneidensis. 
The number of recombinants obtained when expressing λ Red Beta or RecT was marginally above 
that of the recombinase-independent control. As shown in other bacteria (Swingle, Markel, et al. 
2010), S. oneidensis is able to recombine ssDNA in a recombinase-independent way at a frequency 
of ~10-4 recombinants/viable cells. According to Li and colleagues (Li et al. 2013), host factors 
such as replicative DNA polymerases and DNA ligase can play a role in completing recombination 
of the ssDNA at the replication fork (Li et al. 2013), which could explain why λ Red Beta and RecT 
are specific to E. coli and did not promote recombination in S. oneidensis. 
In this study, we identified a λ Red Beta recombinase homolog in Shewanella sp. W3-18-
1, termed W3 Beta, and demonstrated its functionality for ssDNA recombineering in S. oneidensis. 
We obtained a recombination efficiency of ~5%, similar to that of studies in E. coli (Ellis et al. 
2001) and higher than previous λ Red Beta and RecT homologous systems found in other bacteria 
(van Kessel & Hatfull 2007; Yin et al. 2015; Yang et al. 2015; Swingle, Bao, et al. 2010; Oh & 
Van Pijkeren 2014; Aparicio et al. 2018; Penewit et al. 2018; Lee et al. 2017). In addition, W3 Beta 
was also functional in E. coli and performed at similar efficiencies to λ Red Beta. The observation 
that W3 Beta outperforms other systems and that it is also functional in phylogenetically distant 
bacteria highlights the efficient recombineering activity of this recombinase.  
Like other phage recombinases, W3 Beta appears to act at the replication fork since it 
displays a strand bias, as do similar systems (Lee et al. 2017; Datta et al. 2008). We found that 
recombineering with W3 Beta results in higher efficiency when electrocompetent cells are prepared 
at room temperature instead of ice-cold temperature in S. oneidensis and E. coli, in agreement with 
our results using λ Red Beta in E. coli. 
The recombineering system described here is the first effective and simple strategy for 
targeted and markerless genome-editing in S. oneidensis, yielding a high efficiency of recombinant 
formation that permits screening for desired mutations in the absence of selection. Our system was 
developed without strain engineering, however  rational removal of single-strand exonucleases 
could potentially enhance efficiency as shown in V. cholera (Dalia et al. 2017) and E. coli (Mosberg 
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et al. 2012; Costantino & Court 2003; Li et al. 2013). In chapter IV, we show that coupling the 
recombineering system developed here with the cutting edge CRISPR/Cas9-technology (Ronda et 
al. 2016; Yan et al. 2017), enables facile isolation of recombinants. In its current state, however, 
this system should facilitate genome editing projects that require precise modifications of small to 
medium-throughput scale. We postulate that this study will pave the way to further strain 
engineering of S. oneidensis.  
 
3.4. Materials and Methods 
 
3.4.1. Bacterial Strains, plasmids and culture conditions 
 
All strains and plasmids used in this study are listed in Table 3.1. Shewanella was routinely 
grown in LB liquid medium or on LB agar at 30 °C. When needed, culture media was supplemented 
kanamycin (Km, 50 µg/mL) or spectinomycin (Spect, 50 µg/mL). Plasmid pBTBX2 from UQ950 
and methylation-minus E. coli GM2163.  
Strain JG2150 was constructed by an in-frame insertion of lacZ from E. coli MG1655 under 
the native promoter of mtrC at the glmS site in S. oneidesis MR-1. In brief, 1kb regions upstream 
and downstream of glmS were amplified and ligated into a suicide vector, pSMV3, which was 
transferred into MR-1 and screened for double recombination events, as previously described 
(Coursolle & Gralnick 2010). 
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Table 3. 1. Strains and plasmids used in this work. 
Strain or plasmid Description Reference or source 
Strain   
JG274 S. oneidensis MR-1, wild type Gralnick Lab 
JG239 Shewanella sp. W3-18-1 Gralnick Lab 
JG98 S. amazonensis SB2B Gralnick Lab 
JG2150 S. oneidensis, lacZ Gralnick Lab 
JG3653 S. oneidensis, pBTBX2 This study 
JG4239 S. oneidensis, pBTBX2 This study 
JG4123 S. oneidensis, pX2SW3Beta This study 
JG4240 S. amazonensis, pX2SW3Beta This study 
JG3909 S. oneidensis, pX2λBeta This study 
JG3916 S. oneidensis, pX2RecT This study 
JG4140 S. oneidensis, lacZ, pBTBX2 This study 
JG4127 S. oneidensis, lacZ, pX2SW3Beta This study 
JG3940 S. oneidensis, lacZ, pX2λBeta This study 
JG3942 S. oneidensis, lacZ, pX2RecT This study 
UQ950 E. coli DH5α λ (pir) host for cloning (Saltikov & Newman 
2003) 
GM2163 E. coli methylation-minus, CmR CGSC#: 6581 
GM1674 E. coli methylation-minus CGSC#7971 
MG1655 E. coli F- lambda- ilvG- rfb-50 rph-1 Gralnick Lab 
JG4130 E. coli, pX2SW3Beta This study 
JG4128 E. coli, pX2λBeta This study 
 
Plasmid 
  
pBTBX2 pBBR1 ori, KmR, pBAD (Prior et al. 2010) 
pX2Cas9 pBBR1 ori, KmR, pBAD, Cas9 Gill lab (Garst et al. 2016) 
pSIM5 pSC101 ori, cmR, pL, λ Red  Court lab 
pBAD-ETg pSC101 ori, pBAD, recET, λ Gam Stewart Lab (Fu et al. 
2012) 
pX2SW3Beta pBBR1 ori, KmR, pBAD, W3Beta This study 
pX2λBeta pBBR1 ori, KmR, pBAD, λ Red Beta This study 
pX2RecT pBBR1 ori, KmR, pBAD, RecT This study 
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3.4.2. DNA manipulations 
 
All primers used in this study are listed in Table 3.2. Plasmid DNAs were isolated using 
Invitrogen Plasmid mini Kit. 
Vectors pX2W3Beta, pX2λBeta and pX2RecT were built using Gibson Assembly. First, 
plasmid pX2Cas9 was linearized by PCR amplification. The recombinase encoding genes were 
PCR amplified with overhang sequences for assembly; sw_1153 was PCR amplified from a 
Shewanella sp. W3-18-1 colony, λ beta from plasmid pSIM5 and recT from pBAD-ETg. 
For colony PCR, a single colony was transferred to 25 µL dH2O, boiled at 95 °C for 5 min 
and frozen at -80 °C for 5 min. The cell debris was removed by centrifugation for 1 min and 2 µL 
of the supernatant were used as a source of template in a 20 µL reaction. GoTaq 2X MM (Promega) 
was used and supplier instructions were followed. After PCR, 10 µL aliquots were analyzed by 
agarose gel electrophoresis. 
	
Table 3. 2. Primers used in this study.  
Name Sequence (5’-> 3’)a Description 
Primers for construction of recombineering plasmids 
ADC102 GGGTATATCTCCTTCTTAAAGTTCGTATC 
Rev primer linearize pX2Cas9 for 
cloning the recombine ORF in place of 
cas9 
ADC103 TCTAGAGAATTCGTCAACGA 
For primer linearize pX2Cas9 for 
cloning the recombinase ORF in place 
of cas9 
ADC116   cgaactttaagaaggagatatacccATGAGTACTGCACTCGCAACG 
For primer to amplify λ-beta for 
cloning in place of cas9 
ADC120 cgttgacgaattctctagaTCATGCTGCCACCTTCTGCT 
Rev primer to amplify λ-beta for 
cloning in place of cas9 
ADC119 cgaactttaagaaggagatatacccATGACTAAGCAACCACCAATC 
For primer to amplify racT for cloning 
in place of cas9 
ADC118 cgttgacgaattctctagaTTATTCCTCTGAATTATCGATTACACTG 
Rev primer to amplify racT for cloning 
in place of cas9 
ADC133 cgaactttaagaaggagatatacccATGGAAAAACCAAAGCTAATCCAACG 
For primer to amplify sw_1153 for 
cloning in place of cas9 
ADC132 cgttgacgaattctctagaCTAAGAAGCTAAAGGCTGTGTGAGCG  
Rev primer to amplify  sw_1153 for 
cloning in place of cas9 
 
Primers for plasmid sequence verification 
 
ADC126 ATACCAGGATCTTGCCATCC For primer to sequence araC 
ADC121 TATGGAACTGCCTCGGTGAG For primer to sequence araC 
ADC122 GACGAAAGTAAACCCACTGG For primer to sequence araC and PBAD 
ADC31 ATTAGCGGATCCTACCTGACG For primer to sequence the recombinase ORF 
ADC33 CGCATCATCAATGAAAACCAGCAG For primer to sequence λ-beta 
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ADC194 ATCCATGATCCAGTGTTCCCGC For primer to sequence sw_1153 
ADC105 AATCCCTGTGGTCAAGCTCG Rev primer to sequence verify soxR terminator and the recombinase ORF 
ADC110  For primer to sequence verify racT 
 
Primers for plasmid analysis 
 
ADC44 GTTTCACTTGATGCTCGATGAG For primer to check for the presence of 
plasmid pBTBX2 in the cells 
ADC105 AATCCCTGTGGTCAAGCTCG Rev primer to check for the presence 
of plasmid pBTBX2 in the cells 
 
Primers for screening recombinants 
 
S. oneidensis  
ADC51 TGGCGTAATAGCGAAGAGG For primer to PCR amplify lacZ and for 
sequencing 
ADC52 CCTGATCTTCCAGATAACTGCC Rev primer to PCR amplify lacZ for 
sequencing 
ADC207 GTGAGCGAGTAACAATTACTTAT
TA 
Rev primer specific to the mutated lacZ 
for PCR amplification/screening 
ADC206 ATGGCAACTGTAAACCAG For primer to PCR amplify rpsL and for 
sequencing 
ADC205 TTAAGACTTAGGACGCTTAGC Rev primer to PCR amplify rpsL for 
sequencing 
ADC208 CAGAGTTAGGTTTCCGTGG Rev primer specific to the mutated rpsL 
for PCR amplification/screening 
S. amazonensis  
ADC229 AAATCAGTTGGTACGTAAGCC For primer to PCR amplify rpsL and for 
sequencing 
ADC230 TTAAGACTTAGGACGCTTGGC Rev primer to PCR amplify rpsL for 
sequencing 
ADC231 GTGCAGAGTTTGGTTTCCGT Rev primer specific to the mutated rpsL 
for PCR amplification 
aLower case designates Gibson assembly overhangs. 
 
 
3.4.3. ssDNA oligo recombineering in S. oneidensis and S. amazonensis 
 
All oligos described in Table S2, were ordered from IDT as 4 nmole ultramer dried DNA 
and suspended in dH2O to a concentration of 0.5 µg.  
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Table 3. 3. Oligonucleotides used for chromosomal mutations.  
Name Sequence (5’-> 3’) 
80nt-lag-lacZ 5’acggttacgatgcgcccatctacaccaacgtgacctatcccattacggtcaatccgccgtttgt
tcccacggagaatccgTAATAAGTAAttgttactcgctcacatttaatgttgatgaaagc
tggctacaggaaggccagacgcgaattatttttgatggcgttaact 
80nt- lead-lacZ 5’agttaacgccatcaaaaataattcgcgtctggccttcctgtagccagctttcatcaacattaaat
gtgagcgagtaacaaTTACTTATTAcggattctccgtgggaacaaacggcggattga
ccgtaatgggataggtcacgttggtgtagatgggcgcatcgtaaccgt 
50nt- lag- lacZ 5’tgacctatcccattacggtcaatccgccgtttgttcccacggagaatccgTAATAAGT
AAttgttactcgctcacatttaatgttgatgaaagctggctacaggaaggcc  
50nt- lead-lacZ 5’ggccttcctgtagccagctttcatcaacattaaatgtgagcgagtaacaaTTACTTATT
Acggattctccgtgggaacaaacggcggattgaccgtaatgggataggtca 
40nt- lag-lacZ 5’cattacggtcaatccgccgtttgttcccacggagaatccgTAATAAGTAAttgttact
cgctcacatttaatgttgatgaaagctggcta 
40nt- lead-lacZ 5’tagccagctttcatcaacattaaatgtgagcgagtaacaaTTACTTATTAcggattct
ccgtgggaacaaacggcggattgaccgtaatg 
40nt- lag-rpsL 5’gacgcacacgagctactttacgtagtgcagagttaggtttCCGTggggtagttgtgtacac
acgtgtacaaacaccacgcttttgt 
40nt- lead-rpsL 5’acaaaagcgtggtgtttgtacacgtgtgtacacaactaccccACGGaaacctaactctgc
actacgtaaagtagctcgtgtgcgtc 
40nt-lag 
SAMArpsLK43R 
5’aacgcacacgagctactttacgcagtgcagagtttggtttCCGTggggcggtggtgtaca
cacgagtacaaacaccacgcttctgt 
 
Plasmids pX2SW3Beta, pX2λBeta and pX2RecT were transformed in host S. oneidensis 
cells JG2150 or JG274 or S. amazonensis cells (JG98), followed by plating on LB + Km and growth 
at 30 °C. The resulting strain cultured on LB + Km was supplemented with arabinose (20 mM) to 
express the recombinase to OD⋍ 0.4-0.5. Cells were made electrocompetent using sorbitol (1 M) 
as wash buffer and incubated with 2.5 µg (5 µL) of ssDNA for three min at room temperature prior 
to electroporation. After electroporation at 12 kV/cm, cells were allowed a 30 min (2 h for rpsL 
recombineering) recovery shacking at 30 °C prior to plating. For the experiments at lower 
temperatures, the same procedure as ice-chilled electrotransformation was followed after keeping 
the cells on ice for 15 or 60 min. 
Following electroporation and the recovery period, aliquots were diluted 104-fold on LB 
medium and all cells of this dilution were spread on LB + Km (50 µg/mL) and X-gal (60 µg/mL) 
agar plates to determine lacZ- cells. To assess the frequency of rpsLK43R mutants, 100 µL of a 
range of 10-fold serial dilutions were plated on LB + Km (50 µg/mL) and Spect (50 µg/mL) agar 
plates at appropriate dilutions to yield single colonies, while viable cells were determined from 
colonies growing on LB + Km (50 µg/mL) plates. A reverse primer specific to the mutation 
introduced (lacZ-mut-R or rpsL-mut-R) was utilized for screening by colony PCR prior to 
sequencing.  
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CHAPTER IV:  
EFFICIENT AND PRECISE GENOME EDITING IN 
SHEWANELLA THROUGH RECOMBINEERING AND 
CRISPR/CAS9-MEDIATED COUNTERSELECTION 
 
This chapter was adapted from “Efficient and Precise Genome Editing in Shewanella with 
Recombineering and CRISPR/Cas9-mediated Counter-selection”, submitted in ACS Synthetic 
Biology, in 2019.	
 
4.1. Introduction 
 
The establishment of ssDNA recombineering has been a major advance for Shewanella 
genome-engineering, but somewhat limited in application in the absence of a robust method for 
counter-selection against unedited cells. In other bacteria, CRISPR (clustered regularly interspaced 
short palindromic repeats)- Cas (CRISPR associated) systems have been adopted as a counter-
selectable marker combined with recombineering, and this combination has proven to be a powerful 
technology for extremely efficient genome engineering (Yan et al. 2017; Jiang et al. 2013; Ronda 
et al. 2016). CRISPR and their associated Cas proteins function as an RNA-guided adaptive 
immune system that allows bacteria and archaea to defend against invading nucleic acids. The 
CRISPR loci consist of arrays of short repetitive sequences separated by short hypervariable 
sequences (spacers), which match regions of viruses and plasmids, and thus represent a recording 
of previous encounters with these foreign genetic elements. Transcription of a CRISPR array by 
the bacterial RNA polymerase yields a long transcript, the pre-crRNA, which is subsequently 
cleaved at the repeated sequences and processed to form specific short mature CRISPR RNAs, 
crRNAs. Primarily via RNA-DNA binding, these crRNAs guide the associated Cas machinery to 
cleave a specific region of the target foreign DNA known as protospacer, which is complementary 
to the spacer sequence. Many CRISPR/Cas systems require the presence of a short 2 to 7nt motif, 
the protospacer-adjacent motif (PAM), juxtaposed to the targeting region of the intruder DNA. The 
existence of the PAM site allows tolerance to self by preventing autoimmunity against the spacers 
from the CRISPR array they encode. Cas-mediated double-stranded DNA (dsDNA) cleavage then 
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results in degradation of the attacker’s genome and thus immunity (Peters et al. 2015; Selle & 
Barrangou 2015).  
There are three major groups of CRISPR/Cas systems, categorized as Type I, II and III, 
which differ in the nature of the cas genes and the mechanism of immunity (Rath et al. 2015; 
Makarova et al. 2012). Type II is the most widely used in genome engineering due to its inherent 
simplicity. Type I and III CRISPR systems are more complex, requiring multiple Cas proteins to 
induce the cleavage of their target foreign DNA. In contrast, Type II systems rely on a simpler 
mechanism, requiring only the crRNA-guided endonuclease Cas9 and an additional trans-encoded 
small RNA (tracRNA) for activity, making it a highly suitable tool for genome-editing. 
Most studies have used the Streptococcus pyogenes Cas9 (SpCas9) Type II system, in 
which a chimeric single guide RNA (sgRNA) has been created to mimic the natural two RNA 
duplexes (Jiang & Marraffini 2015; Garst et al. 2016; Reisch & Prather 2015; Ronda et al. 2016). 
This sgRNA contains a user-programmable 20nt unique spacer (guide sequence) complementary 
to the target allele of choice, and the SpCas9 binding scaffold to form the sgRNA-SpCas9 
ribonucleoprotein complex (Jinek et al. 2012). The first 8-12nt at the 3’- end of the guide are known 
as the ‘seed’ sequence; mutations within this region abrogate Cas9 binding activity, while 
mutations outside the ‘seed’ can be tolerated (Jinek et al. 2012; Jiang et al. 2013). In addition to the 
sgRNA, SpCas9 requires the PAM site sequence, NGG, located at the 3’ end of the DNA target 
(20nt target-NGG) to enable Cas9-mediated recognition of the DNA target and creation of a 
double-strand break (DSB). SpCas9 can also recognize the nt sequence NAG as PAM, albeit with 
much lower efficiency (Jiang et al. 2013). The PAM site is not included in the targeting sequence 
used for the sgRNA. Cas9 nucleases cleave DNA through the combined activity of their RuvC and 
HNH domains, each of which nicks one strand of DNA to generate a blunt-ended DSB. Complete 
Cas9-mediated cleavage of the bacterial chromosome is usually lethal, since most bacteria lack 
endogenous nonhomologous end joining (NHEJ) activity (Peters et al. 2015; Selle & Barrangou 
2015). Thus, Cas9-mediated killing can be used as a powerful tool to enhance selection of genetic 
alterations introduced with recombineering by elimination of chromosomes carrying the wild-type 
(WT) DNA sequence (Peters et al. 2015; Selle & Barrangou 2015). However, care should be taken 
to design spacers with high specificity, since Cas9 bound to weak targeting spacers fails to cut all 
copies of the E. coli chromosome, leading to cell survival via RecA-dependent homologous 
recombination between sister chromosomes (Cui & Bikard 2016). 
Jiang et al. (Jiang et al. 2013) were the first to couple CRISPR/Cas9 to recombineering 
using the λ Red system in E. coli. Using Cas9 as a counter-selection, a recombination efficiency of ⋍65 % of surviving cells was obtained when introducing a point mutation into the rpsL gene. Since 
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then, this hybrid in vivo genetic engineering technology has been successfully transferred to other 
bacterial hosts including T. citrea (Jiang et al. 2015), L. reuteri (Oh & Van Pijkeren 2014), C. 
glutamicum (Sung et al. 2017), P. putida (Aparicio et al. 2018) and S. aureus (Penewit et al. 2018). 
Some of these studies used either several plasmids or expressed components of the two systems 
from the bacterial chromosome. Even though these strategies allow for control over each 
component of the system, a disadvantage is the limited portability to other hosts. We set out to 
explore the possibility of combining ssDNA recombineering with CRISPR/Cas9 in Shewanella to 
enhance our ability to engineer the genome of these bacteria. Here, we describe a simple two-
plasmid system that expresses both Cas9 and the W3 Beta recombinase from one vector and the 
targeting sgRNA from a second vector. Our system enables precise site-directed mutagenesis of 
the bacterial chromosome at a high efficiency (>90%) when the recombinogenic ssDNA oligos and 
the sgRNA plasmid are introduced by co-transformation into the cells harboring Cas9 and W3 Beta. 
Using this system (Fig 4.1) we have successfully modified several different genes and introduced 
various types of mutations including individual base changes and net gene deletions in the model 
strain S. oneidensis MR-1, as well as in S. amazonensis SB2B. This new method not only simplifies 
genetic manipulation of Shewanella, but will facilitate implementation of high-throughput genomic 
engineering technologies. 
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Figure 4. 1.  Overview of ssDNA recombineering combined with CRISPR/Cas9 as a counter-
selection.  
The system consists of two plasmids: pX2C9pLacW3Bet expresses spCas9 from the arabinose 
inducible PBAD promoter, regulated by the arabinose repressor (araC), and the sw_1153 
recombinase from the constitutive PLac promoter; while plasmid pACYC-xxxgRNA constitutively 
expresses the gRNA. For genomic engineering, plasmid pX2C9pLacW3Bet is first introduced into 
host cells by electroporation, and the transformed cells are plated on L Km50 agar medium and 
incubated at 30°C. Plasmid-bearing cells are made electrocompetent and the pACYC-xxxgRNA is 
co-transformed with the ssDNA oligos to generate targeted mutations. After recovery from 
electroporation, cells are plated on L Km25 Cm6.5 agar medium, supplemented with arabinose to 
induce the Cas9-mediated counter-selection, and incubated at 30°C. Mutations are verified by 
colony PCR using specific primers followed by sequencing of the PCR product.	  
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4.2. Results  
 
4.2.1. Lethality of DSB Induced by Active Cas9 in Shewanella 
 
Initially, we asked whether the model bacterium S. oneidensis MR-1 contains any CRISPR 
array or Cas proteins, using the CRISPRDetect webtool, developed by the Brown group at the 
University of Otago (Biswas et al. 2016). No CRISPR/Cas system was identified when the program 
default values were used. We then modified the parameters to look for smaller potential CRISPR 
arrays, and found a possible array consisting of 2 repeats and one spacer located at position 
907,711-907,823 of the chromosome; however, no Cas proteins could be detected. Encouraged by 
our findings, we sought to harness the engineered CRISPR/Cas9 system from S. pyogenes through 
heterologous expression of the key components; the Cas9 nuclease and synthetic chimeric sgRNAs.  
Since a non-specific binding activity associated with overexpression of Cas9 was detected 
at high concentrations (Cobb et al. 2014; Huang et al. 2015; Wang et al. 2018; Cui et al. 2018), we 
modulated expression of Cas9 by placing it under control of the arabinose inducible PBAD promoter 
on the kanamycin (Km) resistant pX2Cas9 plasmid (Garst et al. 2016). As a control we used a 
defective Cas9 (dCas9) from the pdCas9 plasmid (Garst et al. 2016), which binds the target DNA 
sequence but is unable to cleave. S. oneidensis cells harboring active Cas9 displayed a small 
decrease in cell viability at high arabinose concentration (⋍4-fold at 5 mM arabinose) (Figure 4.2), 
thus low arabinose concentrations were required. No decrease in viability was observed with 
inactive Cas9 at any of the concentrations tested. 
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Figure 4. 2. Effect of Cas9 expression on S. oneidensis growth.  
Cells were grown to early exponential phase and induced with different arabinose concentrations 
for 3 hours prior to plating. After induction, different diluted aliquots were spot plated on Km plates 
and incubated at 30°C for ~24 hours. The error bars represent standard error from three independent 
experiments. 
 
To assess the specific lethality of Cas9-induced DSB in S. oneidensis, we expressed 
different combinations of the CRISPR/Cas components. We designed sgRNAs targeting several 
genes on the S. oneidensis chromosome (Table 4.7 and 4.8). The non-essential genes lacZ, exeM 
(encoding an extracellular endonuclease) and mtrA (encoding a periplasmic c-cytochrome from the 
Mtr pathway) were chosen, since mutations that suppress these functions are not detrimental to cell 
growth under aerobic conditions. S. oneidensis MR-1 does not contain an endogenous lacZ gene, 
thus, we used a strain with the E. coli lacZ gene integrated in single copy on the bacterial 
chromosome (Corts et al. 2019), which allowed for rapid quantitation of genome editing events. 
Cells harboring active Cas9 or dCas9 were electroporated with the chloramphenicol resistant 
(CmR) sgRNA expressing plasmid, pACYC-XXXgRNA. For each of these genes, when both Cas9 
and a sgRNA were co-expressed, a large decrease in cell viability was observed. More than 99% 
of the cells were killed, resulting in ⋍102-103 transformants/mL compared to ⋍106 
transformants/mL obtained when Cas9 was not induced (Figure 4.3A). A background of CmR 
colonies appeared on the Km25 Cm6.5 agar plates, at a rate of ⋍101 total colonies/mL (Figure 
4.3A, -DNA control), as observed previously (Groh et al. 2007). Increasing the concentration of 
Cm up to 15 µg/mL did not enhance selection but proved detrimental for the cells. Use of a drug 
marker other than chloramphenicol may enhance editing efficiency in S. oneidensis. The rest of the 
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colonies surviving the DSB are probably cells that acquired mutations in the cas9 gene itself or that 
allow evasion of Cas9 targeting (Garst et al. 2016; Ronda et al. 2016; Stout et al. 2018).  
 
 
Figure 4. 3. Lethality of DSBs induced by active Cas9 in Shewanella.  
a) S. oneidensis, b) S. amazonensis. Results were determined as total colony-forming units (CFU) 
on L agar plates containing both antibiotics, Km and Cm, supplemented with or without arabinose. 
Data are averages of three independent experiments; error bars indicate standard deviation. 
 
In order to evaluate the power of this in vivo genetic engineering technology in another 
Shewanella species, we assessed CRISPR/Cas9 activity in S. amazonensis SB2B. We designed a 
sgRNA to target sama_1213, which encodes for the decaheme cytochrome c MtrD. Using the same 
conditions for S. oneidensis, more than 99% killing was observed in S. amazonensis SB2B, 
resulting in ⋍50 transformants/mL compared to ⋍105 transformants/mL without CRISPR/Cas9 
induction (Figure 4.3B). S. amazonensis appears to be more sensitive to chloramphenicol than S. 
oneidensis, since no spontaneous colonies were observed on the selective plates containing Km25 
and Cm6.5 (Figure 4.3B, -DNA control). As controls, we tested variants deficient in Cas9 cutting, 
using dCas9 (provided from pdCas9) or an empty vector lacking sgRNA (pACYC’). Omitting 
either part of the CRISPR/Cas9 system, Cas9 or sgRNA, eliminated the capacity of Cas9 to be used 
as a counter-selection in both strains tested, since the transformation efficiency was not reduced 
even when induced. This inactivity stands in contrast to the successful CRISPR/Cas9 counter-
selection we observe when both active Cas9 and sgRNA are expressed (Figure 4.3).  
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4.2.2. Recombinase-independents ssDNA genome editing coupled to CRISPR/Cas9 counter-
selection 
 
In chapter III, we found that S. oneidensis can naturally recombine ssDNA without the 
addition of phage-encoded proteins, albeit at a low frequency of ⋍104 recombinants/108 viable 
cells, as had been observed in other hosts (Bryan & Swanson 2011; Swingle, Markel, et al. 2010). 
Thus, we asked whether we could use CRISPR/Cas9 as a counter-selection to eliminate the WT 
copies of a gene after recombination in the absence of any phage recombinase expression, as this 
would provide a very simple genome-editing tool (Figure 4.4). We used 170nt long recombinogenic 
ssDNA donor templates to introduce ten consecutive base pair (bp) changes within the gene open 
reading frame (ORF), which resulted in 10bp mutations coupled with a frameshift (Table 4.6). The 
oligos contain the centered mutations flanked by 80nt homology arms. These mutations also 
introduce a change in the PAM site, to avoid retargeting by Cas9. We targeted lacZ in S. oneidensis 
using an oligo complementary to the lagging strand template, since it has been shown in other 
bacteria that oligos annealing to the lagging strand template results in higher efficiencies (Swingle, 
Markel, et al. 2010). The lacZ gene was used because loss of gene function is easily screened for 
using X-gal supplemented plates, where colonies capable of metabolizing X-gal via activity of the 
lacZ gene product, b-galactosidase, turn blue. Different ratios of sgRNA/ssDNA were evaluated, 
as well as different recovery times after electroporation (Figure 4.5). The optimal result was 
obtained when 250 ng of sgRNA plasmid and 1 µg of ssDNA were co-transformed (ratio 1/4) and 
the cells were recovered for 4 hours prior to applying the CRISPR/Cas9-based counter-selection. 
Under these conditions, an efficiency of ⋍80% mutants among total transformed cells was 
achieved, as confirmed by colony PCR and sequencing (Figure 4.6).  Although the frequency of 
modified cells is the same as in our previous study (Corts et al. 2019) lacking CRISPR/Cas9, ⋍10-
4 recombinants/total cells, the efficiency increased ⋍2x104-fold with the addition of the CRISPR 
system, due to the Cas9-mediated counter-selection.  Given that CRISPR systems are broadly active 
in bacteria, this approach is likely to be generally useful in other species that display a low level of 
recombinase-independent ssDNA recombination and for which no phage mediated recombination 
system has been developed.  
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Figure 4. 4. Overview of CRISPR/Cas9 counter-selection coupled with recombinase-
independent ssDNA genome-editing.  
The system consists of two plasmids, pX2Cas9, expressing SpCas9 under the inducible arabinose 
promoter which is regulated by the arabinose repressor (araC), and the pACYC-xxxgRNA, 
expressing the gRNA to target the gene of interest. Plasmid pX2Cas9 is first introduced into host 
cells by electrotransformation, followed by plating on LB + Km and growth at 30°C. The resulting 
cells are made electrocompetent and ssDNA oligos combined with plasmid pACYC-xxxgRNA are 
co-transformed by electroporation to generate targeted mutations. After recovery, the cells are 
plated on LB + Km + Cm, supplemented with arabinose to induce the Cas9-mediated counter-
selection, and incubated at 30°C. Mutations are verified by colony PCR with specific primers.	  
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Figure 4. 5. Recombinase-independent ssDNA genome-editing coupled to CRISPR/Cas9 
counter-selection. 
 Genome-editing of lacZ a) using different ratios of sgRNA to ssDNA with a 4 hour recovery, b) 
using a ratio of sgRNA plasmid/ssDNA of ¼, but varying recovery times after electroporation. 
Results were determined as total CFU growing on L agar plates containing both Km and Cm and 
supplemented with arabinose. For lacZ modification the solid agar was also supplemented with X-
Gal and efficiency was calculated as the percentage of white (mutant) colonies over the total. Data 
are the average of three independent experiments; error bars indicate standard deviation.  
	
	
Figure 4. 6. Verification of lacZ edits in S. oneidensis using CRISPR/Cas9 counter-selection 
coupled with recombinase-independent ssDNA genome-editing.  
(a) 23 mutants were screened by colony PCR with a reverse primer specific to the DNA change 
introduced, validating the correct mutation in all colonies. ⊘ indicates a PCR negative control of 
wild-type lacZ. (b) Sequence confirmation of 10 recombinants identified by white/blue screening, 
which revealed the mutation of the DNA sequence ACGGG to TAATAAGTAA for all samples, 
as expected. 	  
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4.2.3. SsDNA recombineering coupled to CRISPR/Cas9 counter-selection gives high 
efficiency of genome-editing 
 
Although the previous method results in a high efficiency of editing and is attractive for its 
great simplicity, since it requires only the CRISPR/Cas9 system and ssDNA, for large-scale 
mutagenesis studies, a higher editing efficiency is desired to maximize the number of mutations 
generated. We previously found that expression of the W3 Beta recombinase in S. oneidensis 
increases the frequency of recombinant formation ⋍103-fold when compared to the recombinase-
independent reaction (Corts et al. 2019). Thus, to improve our system, we constructed a vector 
harboring cas9 under the arabinose inducible promoter and the gene encoding W3 Beta under a 
constitutive lac promoter. The resulting plasmid, pX2C9pLacW3Bet editing plasmid (Figure 4.7) 
was tested for any toxicity effect as we previously did with pX2Cas9. No difference in cell viability 
was observed when compared to pX2Cas9 plasmid (Figure 4.2).  
We used recombinogenic ssDNA donor templates complementary to the lagging strand 
template (Figure 4.8 and Table 4.6) of the gene of interest, since we previously observed 50- to 
100-fold improved recombineering efficiency with this strand as compared to the leading strand 
(Corts et al. 2019). We targeted genes lacZ, exeM and mtrA in S. oneidensis and sama_1213 in S. 
amazonensis and used flanking homology arms of different length in the donor ssDNA. Several 
types of mutations were introduced, including single base changes and whole gene deletions 
(Figure 4.10 and Table 4.1), to test the robustness of the system.  
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Figure 4. 7. Plasmid maps of the two-plasmid based system.  
a) pX2C9pLacW3Bet, consists of the arabinose-inducible spCas9 and the constitutively expressed 
sw_1153. b) The gRNA targeting plasmid, pACYC-xxxgRNA, contains the sgRNA chimera 
expressed from the constitutive PLac promoter and encompasses the 20nt region for binding to the 
DNA target, the Cas9 binding hairpin and a terminator derived from S. pyogenes. 
 
	
Figure 4. 8. Representation of lagging strand-targeting oligos in S. oneidensis MR-1 and S. 
amazonensis SB2B genomes.  
(a) Organization of the S. oneidensis MR-1 chromosome showing the location of mtrA and exeM 
genes, and (b) organization of the S. amazonensis SB2B chromosome showing the location of 
sama_1213 and rpsL genes respective to the origin of replication (oriC). The relative position of 
oriC and terminus define two replichores through which DNA synthesis proceeds. As the oligos 
mimic Okazaki fragments at the replication fork, the orientation of the target gene in respect to the 
oriC should be determined in order to obtain optimal recombineering efficiency. Shown in yellow 
are the genes in the 5’-> 3’ direction. Shown in red are the 5’→ 3’ alignment of the recombinogenic 
oligos, which are identical in sequence to the lagging strand and complementary to the lagging 
strand template of each gene.  
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We tested the plasmid pX2C9pLacW3Bet in S. oneidensis by first targeting the lacZ gene 
and using a 170nt oligo with 80nt flanking homology arms that introduces 10 consecutive bp 
changes (Table 4.6). Cells harboring the pX2C9pLacW3Bet were co-transformed with the ssDNA 
and sgRNA plasmid at a ratio 1/4. In contrast to our previous results with the CRISPR/Cas9 system 
alone, we found that a two hour recovery after electroporation prior to plating on solid agar medium 
is sufficient to achieve a maximum editing efficiency of > 90% (Figure 4.9). Thus, we routinely 
used a two hour recovery period. The number of recombinants was also increased ⋍3-fold when 
W3 Beta was being expressed (compare Figure 4.5B and 4.9). As previously observed for ssDNA 
recombineering (Corts et al. 2019), no significant difference in efficiency was found when using 
40nt versus 80nt homology arms to make this 10bp DNA change (Table 4.1). Similarly, an 
efficiency of >90% was obtained when making the same type of mutation in mtrA and exeM in S. 
oneidensis (Table 4.1). All recombinants were verified by colony PCR screen and sequencing 
(Figure 4.11). Compared to our previous recombineering study in S. oneidensis (Corts et al. 2019), 
adding the CRISPR/Cas9 counter-selection results in a ⋍20-fold apparent increase in editing 
efficiency.  
	
 
Figure 4. 9. ssDNA recombineering combined with CRISPR/Cas9 as a counter-selection in S. 
oneidensis.  
The lacZ gene was edited in S. oneidensis using the oligo targeting the lagging strand template with 
80nt flanking homology arms. Cells were co-transformed with the gRNA expressing plasmid and 
ssDNA at a ratio ¼. After different recovery times at 30°C, aliquots were diluted and cells were 
plated on Km + Cm selective agar plates supplemented with arabinose at appropriate dilutions to 
yield single colonies. 
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Strikingly, when deleting the entire mtrA gene, the same high recombination efficiency 
was obtained using an oligo with 80nt flanking homology arms. However, the efficiency dropped 
when shorter flanking arms of 60nt and 40nt were used, to ⋍77% and ⋍8%, respectively (Table 
4.1). Thus, although 40nt homology arms is adequate to obtain maximal efficiency when making 
smaller mutations, longer homologies of 80nt are required to make larger deletions with high 
efficiency in S. oneidensis. Putative recombinants were verified by colony PCR followed by 
sequencing (Figure 4.13) and tested for their inability to reduce iron (Figure 4.15), as previously 
described (Coursolle & Gralnick 2010). As expected, mtrA deletion mutants were unable to reduce 
iron citrate. 
Sawitzke et al. (Sawitzke et al. 2011) showed that in E. coli most single base pair 
mismatches as well as insertions or deletions up to three nucleotides in length are corrected by the 
methyl-directed mismatch repair (MMR) system, which is present in the host. Thus, in order to 
make a 1bp mutation in exeM (amino acid 136, TGG>TGA), we also introduced 4 nearby 
consecutive wobble alterations, which improve the frequency of recombinants in E. coli (Sawitzke 
et al. 2011) but do not alter the amino acid sequence encoded by the modified gene, and allow 
creation of a single amino acid change in the desired protein. Interestingly, a marginally lower 
recombination efficiency of ⋍36% (Table 4.1) was obtained when using an oligo with 40nt of 
homology arms, as opposed to the introduction of 10bp DNA change. This result suggests that this 
combination of mutations may not be sufficient to entirely escape the host MMR system in S. 
oneidensis. Putative recombinants were verified by colony PCR and sequencing (Figure 4.14).  
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Figure 4. 10. Schematics of the mutations created by ssDNA recombineering coupled to 
CRISPR/Cas9 counter-selection.  
a) For mismatches or small insertions, mutations are introduced at the center of the long oligo and 
two homology arms are collated on each side. Short (20-24bp) primers are used to confirm the 
recombinants, as follows: primers #1 and #2 are used for colony PCR screening to verify the 
recombinants, while primers #1 and #3 are used to make a PCR product for sequencing 
confirmation. b) For deletions, the long oligo has homology arms designed to recombine with the 
DNA sequences flanking the gene to be deleted. Short primers #1 and #2 are used for size 
verification of the recombinants and for sequencing. 
 
We performed the 1bp point mutation in exeM two times, each in triplicate, using two 
independently synthesized oligos, both with 40nt homology arms and the same mutations in the 
center of the oligo. One of the oligos gave the expected results after sequencing of 10 colonies, in 
agreement with the colony PCR results. While the second oligo gave the same ⋍36% efficiency 
with the colony PCR screen, but sequencing of 16 colonies showed that ⋍40% of the putative 
recombinants had additional or different unwanted mutations. These undesired DNA alterations 
were 1bp changes, both point mutations and frameshifts, and were located within the region of the 
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chromosome where the oligo anneals and recombines. Thus, this oligo resulted in a slightly lower 
efficiency (⋍22%) of correct isolates. As observed by Oppenheim and colleagues (Oppenheim et 
al. 2004), the unwanted mutations apparently arose during chemical synthesis of the ssDNA oligo. 
Although finding unwanted mutations is infrequent, it is important to confirm the final construct 
by sequence analysis, especially the regions encompassed by the oligo. We tried using shorter 
oligos to minimize the chances of getting these unwanted mutations, however, a lower efficiency 
of ⋍23% was obtained when using 30nt flanking homology arms (Table 4.1). 
 
Table 4. 1. Genome editing of different genes in S. oneidensis and S. amazonensis.  
Oligos complementary to the lagging strand template of the targeted gene with flanking homologies 
of different length were used. Cells harboring the editing plasmid pX2C9pLacW3Bet were co-
transformed with the sgRNA plasmid and ssDNA at a ratio ¼ and recovered for 2 hours after 
electroporation. Transformants were determined as total CFU growing on agar plates with both 
antibiotics, Km and Cm, supplemented with arabinose. For lacZ tests, plates were also 
supplemented with X-Gal. Data shows averages of three independent experiments and error bars 
depict standard deviations.  
Gene Mutation Oligo homology arms 
Transformants 
(CFU/mL) 
Efficiency (% 
positive/total) 
S. oneidensis 
lacZ 
10bp 
80nt 2.00x102 ± 1.39x101 91.23 ± 2.67% a 
40nt 3.33x102 ± 5.67x101 93.96 ± 2.13%a 
No oligo control 2.67 ± 0.67 N/A 
mtrA 
10bp 80nt 5.82x102 ± 4.42x101 93.18 ± 6.82% b 
Δ1002 (gene 
KO) 
80nt 3.58x102 ± 3.10x101 95.45 ± 4.55%b 
60nt 4.90x101 ± 9.04 77.27 ± 4.55%b 
40nt 4.68x101 ± 1.55x101 7.88 ± 1.69% b 
No oligo control 6.51 x10
1 ± 
5.08x101 N/A 
exeM 
10bp 80nt 2.39x103 ± 2.58x102 95.45 ± 0.00% b 
1bp 
40nt 3.90x102 ± 4.67x101 36.36 ± 4.55%b 
30nt 7.83x101 ± 1.85x101 22.73 ± 4.55%b 
No oligo control 1.79x102 ± 6.22x101 N/A 
S. amazonensis  
sama_1213 
10bp 
80nt 4.28 x10
2 ± 
1.19x102 86.36 ± 9.09% 
b 
40nt 2.82x102 ± 1.56 97.73 ± 2.27% b 
No oligo control 9.51 x10
1 ± 
6.18x101 N/A 
N/A: not applicable, aDetermined by white/blue screening, as the % of mutant white recombinant 
colonies over the total number of transformants. Calculated from three independent experiments. 
bDetermined by colony PCR screening of more than 20 transformant colonies with specific primers 
to the mutation introduced (Figure 4.10), as the number of positive recombinants over the total 
number of colonies tested. Calculated from at least two independent experiments.	  
60 
 
We then wished to assess our system in a different Shewanella strain, S. amazonensis. 
Following the same protocol as in S. oneidensis, we observed the same efficiency of >90% 
recombinants among total transformed cells when introducing 10 consecutive base changes in the 
sama_1213 gene, which was further verified by colony PCR screening and sequencing (Figure 
4.12). As with S. oneidensis, no significant difference in frequency was found whether the ssDNA 
oligo contained 40nt or 80nt homology arms (Table 4.1). We previously found the W3 Beta 
recombinase to be also functional in E. coli at the same high efficiency as the λ-Red Beta (Corts et 
al. 2019), thus our system may be active in other bacterial species as well. 
While the results above validate the high potential of this technology in Shewanella, one 
challenge facing Cas9-DSB mediated counter-selection in bacteria is the possibility of off-targeting 
by Cas9 (Cui et al. 2018). However, this can be solved by using different approaches recently 
developed to enhance on-target specificity, such as the use of engineered Cas9 nucleases (Karvelis 
et al. 2017; Lee et al. 2018) or chemically modified sgRNAs (Ryan et al. 2018).   
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Figure 4. 11. Verification of 10bp lacZ, mtrA and exeM mutants by recombineering combined 
with CRISPR/Cas9 counter-selection.  
(a) 23 lacZ mutants identified by white/blue screening were screened by colony PCR with a reverse 
primer specific to the DNA change introduced, validating the correct mutation in all colonies. (b) 
Sequence confirmation of 10 recombinants identified in (a), which revealed the mutation of the 
DNA sequence 5’-ACGGG-3’ to 5’-TAATAAGTAA-3’ for all samples. (c) 22 mtrA putative 
mutants were screened by colony PCR with a reverse primer specific to the DNA change 
introduced, validating the correct mutation in all colonies. (d) Sequence confirmation of 10 
recombinants identified in (c), which revealed the mutation of the DNA sequence 5’-TTTGG-3’ to 
5’-TAATAAGTAA-3’ for all recombinants. (e) 22 exeM putative mutants were screened by colony 
PCR with a reverse primer specific to the DNA change introduced, validating the correct mutation 
in 21 colonies out of the total 22 screened. (f) Sequence confirmation of 10 recombinants identified 
in (e), which revealed the mutation of the DNA sequence 5’-GTGG-3’ to 5’-TGATGAGTAA-3’ 
for all recombinants. ⊘ indicates a PCR negative control of the wild-type gene. The PAM sequence 
5’-NGG-3’ is underlined. Oligos with 80nt of flanking homology arms were used.  
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Figure 4. 12. Verification of sama_1213 mutants by recombineering combined with 
CRISPR/Cas9 counter-selection using different size oligos.  
(a) 21 putative sama_1213 mutants created using an oligo with 80nt of flanking homology arms 
were screened by colony PCR with a forward primer specific to the DNA change introduced, 
validating the correct mutation in 20 colonies. (b) Sequence confirmation of 8 recombinants 
identified in (a), which revealed the mutation of the DNA sequence 5’-CCGAT-3’ to 5’-
TAATAAGTAA-3’ for all samples. (c)  22 putative sama_1213 mutants created using an oligo 
with 40nt of flanking homology arms were screened by colony PCR with a forward primer specific 
to the DNA change introduced, validating the correct mutation in all 22 colonies. (d) Sequence 
confirmation of 10 recombinants identified in (c), which revealed the mutation of the DNA 
sequence 5’-CCGAT-3’ to 5’-TAATAAGTAA-3’ for all samples.⊘ indicates a PCR negative 
control of the wild-type gene. The PAM sequence NGG is underlined.  
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Figure 4. 13. Verification of mtrA deletion mutants by recombineering combined with 
CRISPR/Cas9 counter-selection using different size oligos.  
Several putative mtrA mutants created using an oligo with (a) 80nt, (b) 60nt, and (c) 40nt flanking 
homology arms were screened by colony PCR with primers binding outside of the mtrA ORF, 
validating the correct mutation in (a) 20, (b) 18 and (c) 2 colonies, respectively, which showed the 
correct size of 383bp after the deletion. 10 of these correct colonies from each experiment (a) and 
(b), and 5 correct colonies from (c) were further sequenced confirming the right knock out 
sequence.⊘ indicates a PCR negative control of the wild-type gene.		 	
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Figure 4. 14. Verification of exeM point mutation by recombineering combined with 
CRISPR/Cas9 counter-selection using different size oligos.  
(a) 22 putative exeM mutants created using an oligo with 40nt of flanking homology arms were 
screened by colony PCR with a reverse primer specific to the DNA change introduced, validating 
the correct mutation in 9 colonies. (c) 22 putative exeM mutants created using an oligo with 30nt 
of flanking homology arms were screened by colony PCR with a reverse primer specific to the 
DNA change introduced, validating the correct mutation in 6 colonies. (b, d) Sequence 
confirmation of 10 recombinants identified in (a and c, respectively), which revealed the point 
mutation TGG>TGA in amino acid 136, in addition to four consecutive wobble changes resulting 
in the DNA sequence 5’-ACCAGTTGGATGA-3’ for all samples. ⊘ indicates a PCR negative 
control of the wild-type gene. The PAM sequence 5’-NGG-3’ is underlined.  
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Figure 4. 15. Iron reduction test of mtrA deletion mutants.  
(a) Iron citrate reduction and (b) ferrozine assay of 5 mtrA mutants. ⊕ indicates a positive control 
able to reduce iron, ⊘ indicates a negative control unable to reduce iron. 
	
4.2.4. System optimization 
 
In order to optimize the expression of the W3 Beta recombinase and thus enhance 
homologous recombination in our system, we modified the DNA sequence located between the PLac 
promoter and the RBS, upstream of the ORF encoding W3 Beta. Our original plasmid contained 
49bp of a random sequence between the PLac and the RBS (Figure 6A and Table S6). We deleted 
bases to make this sequence shorter, hoping to optimize transcription. For that purpose, we created 
two additional plasmid constructs, pX2C9pLac26W3Bet and pX2C9pLac20W3Bet, which have 
26bp and 20bp, respectively, between the PLac and RBS (Figure 6A and Table S6). 
Both of the new constructs resulted in a >10-fold increase in the frequency of 
recombination, while the same efficiency of >90% was maintained. Specifically, 
pX2C9pLac26W3Bet gave the best result with a frequency increase of ⋍30-fold compared to the 
original editing plasmid.   
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Figure 4. 16. System optimization.  
a) Representation of the promoter and RBS upstream sequence of sw_1153 for each of the three 
plasmid constructs. b) Recombination frequencies of lacZ in S. oneidensis using each plasmid 
construct. An oligo with 80nt of homology arms was used to target the lagging strand of lacZ. Cells 
harboring the corresponding editing plasmid were co-transformed with the sgRNA plasmid and 
ssDNA at a ratio ¼ and recovered for 2 hours after electroporation. Transformants were determined 
as total CFU growing on agar plates with both antibiotics, Km and Cm, supplemented with 
arabinose and X-Gal. Viable cells were evaluated as CFUs growing on agar plates with Km and X-
Gal only. Data shows averages of at least three independent experiments and error bars depict 
standard deviations. 
 
Shewanella genome manipulation is limited by a lack of plasmid curing techniques and 
available inducible promoters for gene expression. Since most members of this family grow at low 
temperatures, high temperature-sensitive origins of replication cannot be used, thus development 
of better methods for conditional expression systems are needed. One option is the use of an 
additional sgRNA to kill the vector backbones, similar to the studies done by Jiang et. al. (Jiang et 
al. 2015) and Ronda et. al. (Ronda et al. 2016). The sgRNA could also be expressed from the same 
editing plasmid, although this strategy may be inconvenient for iterative genome-editing studies.  
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4.3. Discussion 
 
For more than 20 years, random mutagenesis has been the most powerful large scale 
technique to manipulate the Shewanella genome. Recently, the combination of recombineering 
with CRISPR/Cas9 as a counter-selection was shown to result in high efficiency of genome-editing 
in different bacteria (Jiang et al. 2015; Oh & Van Pijkeren 2014; Sung et al. 2017; Aparicio et al. 
2018; Penewit et al. 2018; Jiang et al. 2013), and has been adapted in E. coli for multiplex genome 
engineering such as the CRMAGE (CRISPR Optimized MAGE recombineering) study (Ronda et 
al. 2016), as well as for generation of high-throughput libraries using CREATE (CRISPR-enabled 
trackable genome engineering )(Garst et al. 2016). Although use of CRISPR/Cas9 for making 
mutations has been proven to be widely applicable to a variety of eukaryotes and prokaryotes (Hsu 
et al. 2015; Jiang & Marraffini 2015; Komor et al. 2017; Mali et al. 2013; Cong et al. 2013), 
recombineering is more host-specific since it requires the use of bacteriophage proteins (Datta et 
al. 2008), however it allows creation of sophisticated, precise genetic editing. The phage 
recombinase proteins are generally single-stranded annealases, which target linear ssDNA to the 
lagging strand template of replication forks at gaps generated during discontinuous DNA 
replication (Ellis et al. 2001). In a recent study (Corts et al. 2019), we reported a new phage-
recombinase, W3 Beta from Shewanella sp. W3-18-1, which gives a robust efficiency of precise 
mutagenesis (Corts et al. 2019), although a screen or selection is still needed to identify 
recombinants. Here, we have increased the ease of recombinant isolation by combining 
recombineering with the powerful technology CRISPR/Cas9 used as a counter-selection against 
non-recombinants. The result is highly efficient genome-editing that greatly expands the genetic 
engineering capabilities in Shewanella. 
The minimal plasmid-based system that we have established may be broadly transferable 
to other related microbes, given that the origins of replication pBBR1 and p15a are functional. The 
editing plasmid contains Cas9 under the arabinose inducible PBAD promoter, with the downstream 
W3 Beta recombinase made constitutively from the lac promoter. The basic procedure has three 
steps. First, the editing plasmid is transferred into the bacterial cells to be modified. Next, a second 
plasmid encoding the targeting sgRNA and the linear ssDNA oligo containing the desired genetic 
changes are co-electroporated into these cells. Since the recombinase is constitutive, modification 
of the chromosomal target gene by W3 Beta using the ssDNA substrate occurs while the cells 
recover from electroporation. Finally, the cells are plated on solid agar medium containing 
arabinose, which induces the Cas9 nuclease. Cas9 introduces a double-strand break at unmodified 
DNA targets, leading to their degradation by cellular nucleases and allowing efficient elimination 
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of the wild type genetic background. This system offers great advantages since the sgRNA can be 
programmed by simply inserting a 20nt short spacer into the sgRNA scaffold, and ssDNA oligos 
can be used for homologous recombination with flanking homology arms as short as 40nt. The only 
limitation is the presence of a nearby three nt PAM site (NGG) in the target sequence, which is 
necessary for Cas9 cleavage. 
Three key elements of this system are: 1) Presence of the PAM site near the desired 
mutation site, since a silent PAM mutation is included in the recombinogenic ssDNA  oligo to 
prevent Cas9 from cleaving the modified DNA sequence (Ronda et al. 2016; Garst et al. 2016). 2) 
To achieve high efficiencies with ssDNA recombineering, proper oligo design is critical. Care 
should be taken to locate the desired change centrally in the oligo. Use of a ssDNA oligo 
complementary to the lagging strand template of the target gene improves editing efficiency up to ⋍100-fold compared to the leading strand (Ellis et al. 2001; Corts et al. 2019). Additionally, 
improved recombineering frequencies were obtained in E. coli when the host MMR was evaded by 
either making more than three consecutive mismatches or adding 4-5 wobble changes in codons 
adjacent to the desired mismatch (Sawitzke et al. 2011). 3) The cells should recover for several 
hours after electroporation and before CRISPR/Cas9 is induced with arabinose. This allows the 
recombination to occur and ensures that bacterial chromosomes have fully segregated before 
applying the negative selection (Ronda et al. 2016). In contrast to traditional targeted mutagenesis 
with suicide vectors or random mutagenesis techniques, our approach is simpler and less labor-
intensive. It will be useful for multiplex and/or iterative genome engineering, as shown in other 
hosts (Garst et al. 2016; Cong et al. 2013; Ronda et al. 2016), and should allow the introduction of 
many types of DNA changes at specific locations (Table 4.2).  
In a recent study (Wu et al. 2019), Wu et al. report use of CRISPR/Cas9 and the RecET 
recombineering system from E. coli Rac prophage to precisely delete three genes in S. algae, using 
a plasmid-born 1kbp long DNA donor substrate  introduced in the cell by conjugation. However, 
RecET recombination activity was not clearly demonstrated in this work, since controls omitting 
the phage recombination system were not presented. It is possible that the reported recombination 
was actually mediated by endogenous Shewanella recombination functions, since RecA proteins 
readily utilize homology arms of this length (Clark et al. 2014). We previously found that E. 
coli RecT is not functional in S. oneidensis (Corts et al. 2019), thus, W3 Beta is likely a better 
choice for homologous recombination in S. algae. Additionally, SpCas9 was expressed from the 
constitutive S. pyogenes promoter in this study, but controls to demonstrate Cas9 activity were 
lacking. We found that Cas9 must be tightly regulated since high Cas9 expression leads to a loss in 
cell viability, as shown in other bacteria (Cobb et al. 2014; Cui et al. 2018; Huang et al. 2015; Wang 
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et al. 2018). CRISPRi was also recently applied in S. oneidensis for transient control of gene 
expression with the defective dCas9 protein (Cao et al. 2017), however, CRISPRi is not a tool for 
site-directed mutagenesis (Table 4.2). 
 
Table 4. 2. Comparison of different genome editing techniques in Shewanella. 
Method 
Suicide-
plasmid 
technique 
Transposon 
mutagenesis Recombineering CRISPRi 
Recombineering 
coupled to 
CRISPR/Cas9  
Purpose Knock-out Random mutagenesis 
Precise 
mutations 
Regulation 
of gene 
expression 
Precise 
mutations 
Efficiency or 
Frequency ⋍10-4a ⋍ 105b ⋍5%a 0-180-foldc 30- >90%d 
DNA delivery conjugation conjugation electroporation conjugation electroporation 
Time spent ~2 weeks ~1 week 4 days < 1 week 4 days 
Labor Intensive Low Low Low Low 
Homology 
arms for 
recombination 
⋍1kbp N/A 40nt N/A 40nt 
Plasmid 
construction 
Multiple 
PCR No No 
Golden 
Gate 
Assembly 
One step Gibson 
Assembly 
Possibility of 
multiplexing No No Yes Yes Yes 
Genomic 
sequence Required Not required Required Required Required 
Other 
constrains 
Essential 
genes 
cannot be 
mutated 
Essential 
genes cannot 
be mutated, 
primarily 
loss of 
function 
mutations 
Plasmid not yet 
curable 
Polarity on 
downstream 
genes, 
plasmid not 
curable 
Plasmid not yet 
curable 
aMeasured as the number of recombinants among total viable cells (Saltikov & Newman 2003; 
Blomfietd et al. 1991; Corts et al. 2019), bCFU/µg DNA in E. coli MG1655 (Gray et al. 2015; 
Yang et al. 2014), cMeasured as repression of GFP expression (Peters et al. 2016; Cao et al. 
2017), dDetermined as the number of recombinants among the total surviving cells (this work). 
N/A: Not applicable 
 
To our knowledge, the work presented here is the first demonstration of CRISPR/Cas9 
used in conjunction with recombineering as a counter-selection in Shewanella. We have 
successfully made and isolated genetic recombinants that contain precise alteration of a single base 
pair as well as complete gene deletions in both S. oneidensis and S. amazonensis. We expect that 
this hybrid recombineering-CRISPR/Cas9 will be a transformative technology for Shewanella. 
Computational guide RNA design resources, as listed in Zhang’s lab web (zlab.bio/guide-design-
resources), will ease the use of our technology. 
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Similar to the high-throughput technologies developed in E. coli such as MAGE (Wang et 
al. 2009) and CREATE (Garst et al. 2016), our system will facilitate generation of comprehensive 
libraries large enough to interrogate the metabolism of Shewanella, facilitating better understanding 
of the EET capabilities and engineering of platform strains for use in biotechnology. We suspect 
that this method will become an essential tool for Shewanella researchers, and as the CRISPR/Cas 
technology advances, others will be able to quickly refine its applicability.  
	
4.4. Materials and Methods 
	
4.4.1. Strains, plasmids, oligonucleotides and growth conditions 
 
Bacterial strains, plasmids and oligos used in this study are given in Table S1 and S2. E. 
coli UQ950 was used as a cloning host. E. coli methylation-deficient strains GM2163 and GM1674 
were used to purify plasmids with KmR and CmR, respectively, prior to electroporation in 
Shewanella. These strains contain a mutation in the DNA-cytosine methyltransferase (dcm--6) that 
prevents methylation of cytosine residues, and thus, plasmids purified from these strains result in 
improved electro-transformation efficiency(Corts et al. 2019). S. oneidensis MR-1 and S. 
amazonensis SB2B were used for genome-editing purposes. E. coli was grown at 37°C and 
Shewanella at 30°C in LB. Oligonucleotides and gblocks were synthesized by Integrated DNA 
Technologies (IDT) and obtained as desalted. Km (50 µg/mL for both species), Cm (30 µg/mL for 
E. coli, 10 µg/mL for S. oneidensis and S. amazonensis), X-gal (60 µg/mL for S. oneidensis) and 
Spect (100 µg/mL for S. amazonensis) was added as needed. Antibiotic concentrations were 
reduced to Km 25 µg/mL and Cm 6.5 µg/mL when Shewanella strains harbored two plasmids. All 
strains were stored in 15% glycerol at -80°C. 
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Table 4. 3. Strains and plasmids used in this study. 
Strain or plasmid Genotype/relevant characteristics Source 
 S. oneidensis    
JG274 Wild type MR-1 Gralnick lab 
JG3514 pX2Cas9 This study 
JG3638 pdCas9 This study 
JG3653 pBTBX2 (Corts et al. 2019) 
JG2150 lacZ (integrated downstream of glmS) (Corts et al. 2019) 
JG4250 pX2C9pLacW3Bet This study 
JG3675 JG2150, pX2Cas9 This study 
JG4226 JG2150, pdCas9 This study 
JG4251 JG2150, pX2C9pLacW3Bet This study 
JG4284 JG2150, pX2C9pLac26W3Bet This study 
JG4285 JG2150, pX2C9pLac20W3Bet This study 
 
S. amazonensis  
  
JG98 Wild type SB2B Gralnick lab 
JG4232 pACYC’ This study 
JG4233 pdCas9 This study 
JG4234 pX2Cas9 This study 
JG4271 pX2C9pLacW3Bet This study 
 
E. coli  
  
UQ950 E. coli DH5α λ (pir) host for cloning (Saltikov & 
Newman 2003) 
MG1655 E. coli F- lambda- ilvG- rfb-50 rph-1 Gralnick lab  
GM2163 dcm- dam- strain for electroporation, 
CmR  
CGSC#: 6581 
GM1674 dcm- dam- strain for electroporation CGSC#7971 
JG3939 MG1655, pX2Cas9 This study 
JG4236  GM2163, pX2Cas9 This study 
JG4122 UQ950, pBTBX2 (Corts et al. 2019) 
JG4059 MG1655, pBTBX2 (Corts et al. 2019) 
JG3649  GM2163, pBTBX2 (Corts et al. 2019) 
JG3938 MG1655, pdCas9 This study 
JG3656  GM2163, pdCas9 This study 
JG4248 UQ950, pX2C9pLacW3Bet This study 
JG4249 GM2163, pX2C9pLacW3Bet This study 
JG4286  UQ950, pX2C9pLac26W3Bet This study 
JG4287  UQ950, pX2C9pLac20W3Bet This study 
JG4228 UQ950, pACYC’ This study 
JG4229 GM1674, pACYC’ This study 
JG4241 UQ950, pACYC’-mtrAgRNA This study 
JG4244 GM1674, pACYC’-mtrAgRNA This study 
JG4242 UQ950, pACYC’-exeMgRNA This study 
JG4245 GM1674, pACYC’-exeMgRNA This study 
JG4048 UQ950, pACYC’-lacZgRNA This study 
JG4288 GM1674, pACYC’-lacZgRNA This study 
JG4243 UQ950, pACYC'-sama_1213gRNA This study 
JG4246 GM1674, pACYC'-sama_1213gRNA This study 
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Plasmids 
  
pBTBX2 pBBR1 ori, KmR (Garst et al. 2016) 
pX2Cas9 pBBR1 ori, KmR, Cas9 (Garst et al. 2016) 
pdCas9 pBBR1 ori, KmR, dCas9 (Garst et al. 2016) 
pX2W3Bet pBBR1 ori, KmR, W3 Beta (Corts et al. 2019) 
pACYC’ Modified pACYC184, p15a ori, CmR  (Corts et al. 2019) 
pACYC’-mtrAgRNA sgRNA-mtrA This study 
pACYC’-exeMgRNA sgRNA-exeM This study 
pACYC’-lacZgRNA sgRNA-lacZ This study 
pACYC'-
sama_1213gRNA 
S. amazonensis sgRNA-sama_1213 This study 
pX2C9pLacW3Bet pBBR1 ori, kmR, Cas9, W3 Beta 
(PLac+49) 
This study 
pX2C9pLac26W3Bet pBBR1 ori, kmR, Cas9, W3 Beta 
(PLac+26) 
This study 
pX2C9pLac20W3Bet pBBR1 ori, kmR, Cas9, W3 Beta 
(PLac+20) 
This study 
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Table 4. 4. Primers used in this study.  
Primer Sequence (5’-3’)a Purpose 
Primers for plasmid modifications  
ADC212 aaagcgctcacacagcctttagcttcttagTCTAGAGAA
TTCGTCAACGA 
Forward primer to linearize 
pX2Cas9 for cloning in W3Beta 
under PLac, with overhangs for 
GA 
ADC213 aaaataggcgtatcacgaggccctttcgtcTCAGTCACC
TCCTAGCTGA 
Reverse primer to linearize 
pX2Cas9 for cloning in W3Beta 
under PLac, with overhangs for 
GA 
ADC227 TTTATGCTTCCGGCTCGTATGTTGTGTG
GATAATGGTTTCTTAGACGTCAGGTGG
CACTAGGAGATATACCCATGGAAAAA
CCAAAGCTAATCCAACG 
Forward primer to amplify 
W3Beta with overhangs to 
introduce PLac 
ADC228 GACGAAAGGGCCTCGTGATACGCCTAT
TTTTATAGGTTAATGTCATGATATTTAC
AC 
TTTATGCTTCCGGCTCGTATGTTGTG 
Forward primer for a 2nd round of 
PCR of W3Beta with overhangs 
to introduce a spacer between 
Cas9 stop codon and PLac 
ADC135 CTA AGA AGC TAA AGG CTG TGT GAG 
CG 
Reverse primer to amplify 
W3Beta for cloning in pX2Cas9 
ADC236 AGGAGATATACCCATGGAAAAACCAA
AGC 
Forward primer to modify 
pX2C9pLacW3Beta to reduce the 
space between PLac and W3Beta 
ORF by blunt ligation 
ADC235 TCCACACAACATACGAGCCGG Reverse primer to modify 
pX2C9pLacW3Beta to reduce the 
space between PLac and W3Beta 
ORF to be 20bp by blunt ligation 
ADC237 CCATTATCCACACAACATACGAGCCG Reverse primer to modify 
pX2C9pLacW3Beta to reduce the 
space between PLac and W3Beta 
ORF to be 26bp by blunt ligation 
 
Primers for sequencing verification of pX2C9pLacW3Bet plasmid variants 
ADC126 ATACCAGGATCTTGCCATCC To sequence verify araC 
ADC122 GACGAAAGTAAACCCACTGG To sequence verify araC, PBAD 
ADC31 ATTAGCGGATCCTACCTGACG To sequence verify cas9 
ADC127 GCGCATATGATTAAGTTTCGTGGTC To sequence verify cas9 
ADC128 GTGAAGATTTGCTGCGCAAG To sequence verify cas9 
ADC129 AGATAGGGAGATGATTGAGG To sequence verify cas9 
ADC130 TCGTGGTAAATCGGATAACG To sequence verify cas9 
ADC131 TGTCAAGAAAACAGAAGTACAGAC To sequence verify cas9 
ADC32 TAAACGGATGCTGGCTAGTGC To sequence verify cas9 
ADC202 ATGGAAAAACCAAAGCTAATCCAACG To sequence verify sw_1153 
ADC105 AAT CCC TGT GGT CAA GCT CG To sequence verify sw_1153 
 
Primers for sgRNAs cloning and sequencing verification 
ADC7 ATGTTCCGGATCTGCATCGC Forward primer to amplify 
sgRNA gblocks 
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ADC8 CCG TGT GCT TCT CAA ATG CCT G Reverse primer to amplify 
sgRNA gblocks 
ADC9 GCG ATG CAG ATC CGG AAC AT Forward primer to amplify 
pACYC' for sgRNA cloning 
ADC10 CAG GCA TTT GAG AAG CAC ACG G Reverse primer to amplify 
pACYC' for sgRNA cloning 
ADC11 TGA GAG TCA ACG CCA TGA GC For sequencing sgRNAs after 
cloning 
Primers for sequencing verifications of mutants 
S. oneidensis mutants  
ADC12 CAG CTA GTA CAG ACT TCC ATT TCC 
G 
Forward primer to sequence 
verify mutations in mtrA 
ADC13 CTG CAG TTA TGG CAT TAG TCG TC Reverse primer to sequence verify 
mutations in mtrA  
ADC14 GGC AAT ACA GCA ATA GAT CTT ACC 
GG 
Forward primer to sequence 
verify mutations in exeM 
ADC15 GGT TAC TTC GCT TTC AGA CTC G Reverse primer to sequence verify 
mutations in exeM  
ADC51 TGG CGT AAT AGC GAA GAG G Forward primer to sequence 
verify mutations in lacZ 
ADC52 CCT GAT CTT CCA GAT AAC TGC C Reverse primer to sequence verify 
mutations in lacZ  
S. amazonensis mutants  
ADC232 CATGGCATTGCTGACACAGC Forward primer to sequence 
verify mutations in sama_1213  
ADC233 GATCACCTTCGGTAAAGACGC Reverse primer to sequence verify 
mutations in sama_1213  
 
Primers for colony PCR screening of mutants 
S. oneidensis mutants  
ADC207 GTGAGCGAGTAACAATTACTTATTA Reverse primer for colony PCR 
screen of 10bp lacZ mutant 
ADC209 CGAGCCGATGATCACTTAATAAGTAA Reverse primer for colony PCR 
screen of 10bp mtrA mutant 
ADC48 AGC CCC CAA CTT ACT CAT CA Reverse primer for colony PCR 
screen of 10bp exeM mutant 
ADC238 CAA GCC CTC ATC CAA CTG GT Reverse primer for colony PCR 
screen of 1 bp exeM mutant 
ADC239 TTCGGTGCAGTTGTTGATGG Forward primer for colony PCR 
screen of mtrA KO mutant 
ADC240 GCTGTTATAACCGACACCGA Reverse primer for colony PCR 
screen of mtrA KO mutant 
S. amazonensis mutants  
ADC234 GATCACCTTCGGTAAAGACGC Reverse primer for colony PCR 
screen of 10bp sama_1213 
mutant 
aLower case designates Gibson assembly (GA) overhangs. Underline indicates a sequence 
overhang. 
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4.4.2. Plasmid construction 
 
All constructs in this study are given in Table S1. The ssDNA donor template sequences 
and the sgRNA, N20 sequences followed by the PAM are given in Tables S3 and S4, respectively, 
in the supplemental material. To check the specificity of sgRNA binding in the genome, a 
systematic BLAST search for the 10nt seed sequence adjacent to the PAM (full sequence: 5’-N10-
NGG-3’, N being any nt) was performed to predict potential off-targets. Any sgRNA that mapped 
to multiple loci was discarded. Plasmids were extracted using a QIAprep kit (QIAGEN) according 
to the manufacturer’s instructions. For PCR amplifications, Q5 DNA polymerase (NEB) was used. 
The two-plasmid system, in which the Cas9 and W3 Beta are separated from the sgRNA, 
was used for genome editing as shown in Figure 4. Plasmid pX2C9pLacW3Bet consists of cas9 
under the PBAD promoter and sw_1153 under the PLac constitutive promoter, the broad-host range 
origin of replication pBBR1, araC and a kmR gene. pX2Cas9(Garst et al. 2016) was linearized by 
PCR, DpnI digested and ligated by Gibson assembly with the W3 Beta fragment. Sequencing 
confirmed the construct was mutation free. 
Plasmid pACYC’(Corts et al. 2019), with a p15a origin of replication, was the vector 
backbone of choice for carrying the sgRNA, which is expressed under the lac promoter and was 
synthesized de novo. Four gblocks were ordered to target genes exeM (SO_1066), mtrA (SO_1777) 
and lacZ in S. oneidensis, and sama_1213 in S. amazonensis. The sequences of the gblocks are 
given in Table S5. Each gblock sequence had 20bp of homology to the pACYC’ plasmid backbone 
for cloning by Gibson assembly. pACYC’ was first linearized via PCR and DpnI digested. gblocks 
were resuspended following manufacturer’s instructions and PCR amplified. PCR products were 
then PCR purified and cloned to form pACYC’-mtrAgRNA, pACYC’-exeMgRNA, pACYC’-
lacZgRNA and pACYC’-sama_1213gRNA.   
Usually, ssDNA donor templates for recombineering were 170nt or 90nt long with the 
mutations located in the center of the sequence and 80nt or 40nt, respectively, of flanking homology 
to the target on each side of the mutation. For mtrA gene knock outs, the donor templates were 
160nt, 120nt or 80nt, containing 80nt, 60nt or 40nt, respectively, of flanking homology outside of 
the ORF. For introducing 1bp change in exeM, the ssDNA template contained 4 wobble consecutive 
mutations in addition to the desired DNA change in the center, and either 40nt or 30nt flanking 
homology arms. 
Blunt end ligation was used to shorten the space between the PLac and the RBS of sw_1153 
in the pX2C9pLacW3Bet editing plasmid, forming pX2C9pLac20W3Bet and 
pX2C9pLac26W3Bet, with promoter sequences as shown in Table S6. pX2C9pLacW3Bet was 
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linearized by PCR using primers ADC235-237 shown in Table S2, followed by DpnI digestion and 
blunt ligation using NEB T4 DNA ligase and T4 polynucleotide kinase. All plasmid clones were 
sequence verified to confirm the absence of mutations.  
 
Table 4. 5. PLac promoter sequences. 
Name sequence (5’-3’)a,b,c 
pLac+49 tttacactttatgcttccggctcgtatgttgtgtggataatggtttcttagacgtcaggtggcactAGGAGA
tatacccATG 
pLac+26 tttacactttatgcttccggctcgtatgttgtgtggataatggAGGAGAtatacccATG 
pLac+20 tttacactttatgcttccggctcgtatgttgtgtggaAGGAGAtatacccATG 
a Underlined are the -35 and -10 boxes, b in bold is the +1 transcriptional start site, c uppercase 
designates the RBS and start codon. 
 
4.4.3. Electroporation 
 
Electroporation was performed at room temperature as previously reported(Corts et al. 
2019). Cells were grown to the desired OD600, then three ml cells were spun by centrifugation at 
7,607 rcf for one minute. Three cell pellets were combined by resuspending them altogether with 
one ml of washing buffer, 1 M sorbitol (pH 7.6). Cells were washed a total of three times prior to 
electroporation by centrifugation at 7,607 rcf for one minute. When using overnight cultures, only 
one ml cells was used and centrifugations were 3 min.  Cells were electroporated with DNA at 12 
kV/cm in 0.1 cm cuvettes. Following electroporation, 1 ml L broth was immediately added to the 
cuvette, and the mixture was transferred to a 2 mL tube for 2 hours outgrowth at 30°C. All 
experiments were performed in triplicate. This protocol may need modification for use in other 
Shewanella strains. 
 
4.4.4. CRSPR/Cas9 activity assessment 
 
The efficiency of CRISPR/Cas9 cutting was determined by co-expressing a sgRNA and 
Cas9. All sgRNA expressing plasmids (250 ng) were electroporated into early exponential phase 
cells (OD600⋍0.5) harboring either Cas9 (pX2Cas9) or dCas9 (pdCas9). Following electroporation, 
S. oneidensis cells were recovered for 4 hours, while S. amazonensis were recovered for 2 hours 
prior to plating on selective petri plates. In parallel, mock transformation controls lacking a sgRNA 
plasmid were performed to assess whether transformed cells would grow on selective plates with 
Km and Cm. All sgRNA plasmids had been purified from methylation-deficient E. coli GM1674. 
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Measurements to determine the viability of cells and transformation efficiency were performed in 
triplicate. 
 
4.4.5. ssDNA genome-editing combined with CRISPR/Cas9 counter-selection 
 
The sgRNA expressing plasmids were first co-electroporated with ssDNA donor templates 
at different ratios in S. oneidensis cells expressing Cas9 in the absence of a phage recombinase 
(Figure S4). Cells were grown to OD600⋍0.5 and electroporation was performed as explained 
above. Cells were recovered in one ml L broth at 30°C for different times prior to plating on 
selection plates. Controls lacking sgRNA plasmid and ssDNA were performed to assess the number 
transformed cells that are spontaneously resistant to Cm. 
For genome editing using recombineering, all sgRNA expressing plasmids were co-
electroporated with ssDNA donor templates at a ratio of ¼ (250 ng of gRNA plasmid and 1 µg 
ssDNA) into S. oneidensis or S. amazonensis cells harboring both Cas9 and W3 Beta from 
pX2C9pLacW3Bet (Figure 1). Cells were recovered in one ml L broth at 30°C for 2 hours prior to 
plating. As controls, the same experiments were done without adding ssDNA donor template, to 
determine the number of colonies escaping from the Cas9-mediated DSB. At least three 
independent experiments were performed to determine recombination efficiencies. All sgRNA 
plasmids were purified from methylation-deficient E. coli GM1674. 
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Table 4. 6. Oligonucleotides used for homologous recombination. 
Name Sequence (5’-3’)a 
S. oneidensis   
80nt-lag-lacZ 5’acggttacgatgcgcccatctacaccaacgtgacctatcccattacggtcaatccgccgtttgttccc
acggagaatccgTAATAAGTAAttgttactcgctcacatttaatgttgatgaaagctggctaca
ggaaggccagacgcgaattatttttgatggcgttaact 
40nt- lag-lacZ 5’cattacggtcaatccgccgtttgttcccacggagaatccgTAATAAGTAAttgttactcgctc
acatttaatgttgatgaaagctggcta 
80nt-lag-exeM 5’ttcccactgggcaggattaaagacagtatttgccactaatgagtcaagcttgcgcttaagggtaacat
caagcccccaacTTACTCATCAaggggttggcacgtcaccaataatatcgacaaccgcacc
atctttaactaaggcaaccgcatcgccaccgttaaaactta 
40nt-lag-exeM-1bp 5’ctaatgagtcaagcttgcgcttaagggtaacatcaagcccTcaTccAacTggTgttggcacgtc
accaataatatcgacaaccgcaccatctt 
30nt-lag-exeM-1bp 5’aagcttgcgcttaagggtaacatcaagcccTcaTccAacTggTgttggcacgtcaccaataata
tcgacaacc 
80nt-lag-mtrA 
 
5’caatggctggcctgcaatgtgaggcatgccacggcccactgggtcagcacaacaaaggcggcaa
cgagccgatgatcactTAATAAGTAAtaagcaatcaaccttaagtgccgacaagcaaaacag
cgtatgtatgagctgtcaccaagacgataagcgtatgtcttgga 
80nt-lag-mtrA-KO 
 
5’gtgaaaatgtaatttgcccaagcagggggagctcgctccccctttcttgaattttgttgggacaaattg
ggaagcctattggagacgagaaaatgaaatttaaactcaatttgatcactctagcgttattagccaacac
aggcttggccgtcgctgctga 
60nt-lag-mtrA-KO 5’agcagggggagctcgctccccctttcttgaattttgttgggacaaattgggaagcctattggagacga
gaaaatgaaatttaaactcaatttgatcactctagcgttattagccaacaca 
40nt-lag-mtrA-KO 5’cctttcttgaattttgttgggacaaattgggaagcctattggagacgagaaaatgaaatttaaactcaat
ttgatcactc 
 
S. amazonensis  
 
80nt-lag-
SAMA_1213 
5’cccaggcttccgtggggattgtggcagtcactgcacaccatctggccgttttcgactggatgactgg
agcgcttgtggatTTACTTATTAccttttgttcgagatgacacgcagtacacacctcgacttcgg
tggctctttgctgaaccggatccttggcagtatggatc 
40nt-lag-
SAMA_1213 
5’tctggccgttttcgactggatgactggagcgcttgtggatTTACTTATTAccttttgttcgaga
tgacacgcagtacacacctcgacttc 
a Uppercase designates the mutations introduced.  
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Table 4. 7. Spacers used for sgRNA/Cas9 targeting. 
Name 20nt spacer sequence + PAM (5’-3’) 
S. oneidensis   
SO_mtrA-gRNA AACGAGCCGATGATCACTTTTGG 
SO_exeM-gRNA TGGTGACGTGCCAACCCCTGTGG 
SO_lacZ-gRNA GTTCCCACGGAGAATCCGACGGG 
S. amazonensis   
sama_1213-gRNA ACTGGAGCGCTTGTGGATATCGG 
 
Table 4. 8. gBLOCKS containing the synthetic sgRNA sequences. 
Name sequence (5’-3’)a 
S. oneidensis   
SO_mtrA-gRNA ATGTTCCGGATCTGCATCGCtttacactttatgcttccggctcgtatgttgtgtggaac
gagccgatgatcactttgttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttg
aaaaagtggcaccgagtcggtgctttttttCAGGCATTTGAGAAGCACACGG 
SO_exeM-gRNA ATGTTCCGGATCTGCATCGCtttacactttatgcttccggctcgtatgttgtgtggtggt
gacgtgccaacccctggttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttg
aaaaagtggcaccgagtcggtgctttttttCAGGCATTTGAGAAGCACACGG 
SO_lacZ-gRNA ATGTTCCGGATCTGCATCGCtttacactttatgcttccggctcgtatgttgtgtgggttc
ccacggagaatccgacgttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttg
aaaaagtggcaccgagtcggtgctttttttCAGGCATTTGAGAAGCACACGG 
S. amazonensis   
sama_1213-gRNA ATGTTCCGGATCTGCATCGCtttacactttatgcttccggctcgtatgttgtgtggact
ggagcgcttgtggatatgttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttg
aaaaagtggcaccgagtcggtgctttttttCAGGCATTTGAGAAGCACACGG 
a Uppercase designates Gibson assembly homology arms for cloning to pACYC’. 
 
4.4.6. Screening for edited cells 
 
Successful recombination of ssDNA donor template with the bacterial chromosome was 
first screened directly on Km and Cm agar petri plates supplemented with 0.8 mM (0.01%) 
arabinose. In all experiments, uninduced controls were plated on the same medium but lacking 
arabinose to evaluate plasmid transformation efficiency. For lacZ editing, the agar plates also 
contained 60 µg/mL X-Gal and editing efficiency was assessed by the proportion of white colonies 
over the total. When targeting exeM, mtrA and sama_1213, the editing efficiency was assessed with 
a colony PCR screen of >20 colonies from at least two independent experiments. Primers specific 
to the mutation introduced were used for colony PCR (Figure 5). Mutations were additionally 
verified by Sanger sequencing. 
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CHAPTER V:  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
In this dissertation, I introduced and demonstrated utility of new experimental strategies 
that should accelerate efforts to investigate and engineer Shewanella. In Chapter II, I described 
development of a highly efficient electro-transformation protocol for S. oneidensis MR-1 and 
showed its utility in other Shewanella strains. In Chapter III, I described the characterization of a 
new prophage recombinase for recombineering in Shewanella and demonstrate its ability to 
recombine ssDNA oligos, targeting the bacterial genome. In Chapter IV, I demonstrated the use of 
CRISPR/Cas9 as a counter-selection and showed that recombineering coupled to CRISPR/Cas9 
results in extremely high efficiency of genome editing of Shewanella. Each of these strategies has 
limitations, as well as promising future directions that could accelerate our ability to manipulate 
Shewanella. Below, I discuss the drawbacks and next steps for each of these strategies 
 
5.1. Application of electrotransformation in different Shewanella strains 
 
The ability to perform electro-transformation for transferring DNA into cells should benefit 
many genome engineering endeavors. Most high-throughput applications developed in E. coli 
combine parallel DNA synthesis with electroporation as means to transfer massive DNA libraries 
and to use recombineering for rapid genome manipulations. Circular plasmid DNA or pools of 
linear DNA cassettes or oligos can be transferred en masse using electroporation, similar to the 
studies performed using TRMR (Trackable Multiplex Recombineering) (Warner et al. 2010), 
MAGE (Multiplex Automated Genome Engineering) (Wang et al. 2009) and CREATE (CRISPR 
EnAbled Trackable Genome Engineering) (Garst et al. 2016). Warner et al., used TRMR to 
demonstrate the construction of two comprehensive E. coli genomic libraries comprising 8,000 
distinct mutations and gene-trait mapping of these cells under different environments. Wang et al., 
used MAGE to optimize the expression of 24 genes in parallel for the improvement of lycopene 
production. Garst et al., used CREATE to generate over 50,000 mutants in E. coli and to map the 
sequence-activity relationship of the variants for a range of applications. These studies highlight 
the importance and simplicity with which genome engineers can massively transfer DNA into a 
cell population using electroporation. Therefore, the ability to electro-transform DNA into 
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Shewanella should accelerate efforts to engineer this microbe for a wide range of industrial 
applications. 
A limitation of this methodology, however, is the transferability to other organisms and 
even strains within the same species. Different strains have diverse characteristics, and our ability 
to manipulate them would be valuable from both a microbiology and biotechnology perspective. 
Could we apply electroporation for high efficiency of DNA transfer in other Shewanella? One 
major limitation is the host restriction-modification system, which can be evaded by using non-
methylated DNA purified from methylation-deficient E. coli.  However, as demonstrated in this 
dissertation, many other factors play a role as well, such as optical density, washing buffer and 
more, for obtaining the high efficiency required for large-scale studies. Improved strategies for 
parallel electroporation of various samples should facilitate development of electroporation in 
multiple strains and organisms. 
 
5.2. Use of recombineering for different types of DNA changes 
 
With recombineering a much higher range of mutations can be achieved compared to 
traditional deletion libraries using transposons. Recombineering allows scientists to precisely 
introduce any DNA change into the chromosome of a bacterial cell; insertions, point mutations and 
deletions, using linear DNAs(Sharan et al. 2009; Baba et al. 2006; Ellis et al. 2001; Sawitzke et al. 
2011). Wang et al. used MAGE to introduce a pool of ssDNA mutagenic oligos for recombineering 
in E. coli using the λ-Red system. Because of the simplicity of using ssDNA, they were able to 
introduce successful genetic modifications in >30% of the population every 2.5 hours. Thus, 
recombineering is a powerful technology for rapidly generating a library of mutants. Usually, these 
recombinases are host specific (Datta et al. 2008), however, as described in this dissertation I found 
that the Shewanella recombinase W3 Beta seems to be broader host than λ-Beta or RecT, since it 
was functional in E. coli at the same high efficiency as λ-Beta, while λ-Beta and RecT were not 
functional in S. oneidensis. It would be of interest to other microbiologists and genetic engineers to 
know whether W3 Beta is also active in other hosts.  
The current bottleneck is the ability to introduce larger insertions, such as an entire gene or 
cluster of genes. For that purpose, dsDNA recombineering is preferred as longer synthetic DNA 
sequences are less economic and chemical synthesis is size limited, but recombineering requires a 
functional phage exonuclease for recombination of dsDNA (Sharan et al. 2009), as well as the 
recombinase protein. Adjacent to the ORF encoding W3 Beta is a putative exonuclease, perhaps 
functionally associated with W3 Beta. Characterization of this exonuclease in conjunction with W3 
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Beta may open the possibility to transfer larger DNA cassettes by dsDNA recombineering and, 
consequently, allow integration of exogenous pathways for genetic analysis or strain improvement 
in Shewanella. 
 
5.3. CRISPR/Cas9 counter-selection 
 
The use CRISPR/Cas9 of as a counter-selection tool coupled with recombineering provides 
a great advantage for bacterial genome engineering, specially, when the organism is unable to 
otherwise repair the double-stranded breaks created by Cas9, since this results in a very high 
efficiency of selection against unmodified chromosomes (Selle & Barrangou 2015). A big 
limitation, however, is the ability to cure the plasmid backbones at the end of the experiment in 
order to obtain a plasmid-free cell. Since most Shewanella grow at lower temperatures (Hau & 
Gralnick 2007), it would be beneficial to engineer replication origins sensitive at a lower 
temperature range similar to the pS101 origin, which is sensitive at the high temperature of 37°C. 
In this work, I show high efficiency functionality of CRISPR/Cas9 in both S. oneidensis 
and S. amazonensis, thus expanding the genetic tools of different Shewanella. However, other 
strains have fewer tools available.  An option for engineering other strains is to combine the 
expression of the sgRNA and Cas9 in one plasmid in order to easily test the efficiency of the system, 
although this strategy would not allow for iterative studies. Since S. amazonensis also grows at 
37°C, future experiments could be performed in this strain using a gRNA expressing plasmid with 
the pS101 origin for iterative editing, for example. 
 
5.4. Large-scale genome engineering using recombineering coupled to CRISPR/Cas9 
 
Recombineering coupled to CRISPR/Cas9 counter-selection allows an extremely high 
efficiency of genome-editing in Shewanella. This technology, as it currently is demonstrated in this 
dissertation, could be used to develop a small library to engineer the active sites of essential proteins 
from the metal respiratory pathway and, by growing the variants in different environments, we 
could gain further knowledge on the mechanism of metal respiration, for example. However, 
usually high-throughput or multiplex studies are desired to investigate several genotypes en masse 
and/or in parallel, similar to the CREATE (Garst et al. 2016) and MAGE (Wang et al. 2009) studies, 
respectively, which require not only high efficiency but also high frequency of editing.  The 
efficiency depends on how well the CRISPR/Cas9 counter-selection performs, so that the final 
population contains as few unmodified cells as possible. However, the frequency depends on: 1) 
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the effectiveness of DNA transfer and, 2) the probability of recombinant formation using 
recombineering.  
In this dissertation, I maximized electro-transformation of S. oneidensis, obtaining ~106 
transformants/ ug DNA and ~108 transformants/ ug DNA when cells are harvested at early 
(OD600~0.4-0.5) and late (OD600~2) exponential phase. Because recombineering exploits 
replication forks (Thomason et al. 2016), transformation of early exponential phase cells are 
required, which I showed results in a maximum efficiency of ~5% S. oneidensis recombinants 
among the total viable cells transformed. Yet, for recombineering coupled to CRISPR/Cas9 as 
described here by co-electroporation of ssDNA and gRNA plasmid, recombinants on the order of 
102-103 per mL, depending on the gene targeted, are obtained. In order to increase the probability 
of recombination, I enhanced transcription of the recombinase by shortening the sequence space 
between the PLac promoter and RBS upstream of the recombinase encoding gene. This modification 
resulted in a ~30-fold increase in frequency. Nevertheless, this frequency is still ~103 orders of 
magnitude lower than the maximum recombineering efficiency. This difference may be due to the 
inefficiency in co-transformation of multiple different DNA molecules versus a single molecule 
electroporation, but possibly other factors such as the difference in promoter type and plasmid copy 
number and/or stability. Although our system was developed without strain engineering, rational 
removal of single- and double- strand exonucleases could potentially enhance the frequency of 
recombineering as shown in V. cholera (Dalia et al. 2017) and E. coli (Mosberg et al. 2012; 
Costantino & Court 2003; Li et al. 2013). 
In the CREATE study (Garst et al. 2016), three different plasmids were used for expressing 
Cas9, λ-Red and the CREATE cassette. However, having several plasmids increases the metabolic 
burden of the cell and it makes it more challenging to implement in other hosts. In this dissertation, 
I designed this genome-editing technology so that only two vectors are required; one expresses the 
gRNA and the other contains Cas9 made inducible from the PBAD promoter and the W3 Beta 
encoding gene under PLAC, which is constitutive in Shewanella. The latter plasmid is designed such 
that both Cas9 and W3 Beta ORFs share the same terminator. Ideally, however, W3 Beta should 
be made also inducible for tight control over each part of the system. This along with further 
improvements, especially with the ability to perform dsDNA recombineering and curing of the 
vector backbones for iterative experiments, will help build larger-scale technologies similar to the 
CREATE and MAGE studies in E. coli (Garst et al. 2016; Wang et al. 2009).  
Multiplex iterative engineering could allow the rapid design of a strain with various 
reduction abilities of different compounds simultaneously, for instance, by engineering of specific 
promoters and/or RBSs for up-regulation of essential pathways required for metal and oxygen 
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respiration. On the other hand, implementation of a CREATE library for saturation mutagenesis of 
the entire Mtr pathway, for example, could provide a way to deeply interrogate the mechanism of 
metal reduction and improve the metal reduction capabilities of Shewanella. In all, the technology 
shown in this thesis should have an impact on genome-engineering of Shewanella and, potentially, 
other less well-studied microbes. Improvements that could enable this technology to be used for 
large-scale is just a matter of time. 
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